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In 1952 in a report to the British Pharmacological
Society .Amin, Crawford, and Gaddura described the
detection 1 of 5-hyaroxytryptamine (5HT) from brain. Their
subsequent paper (1954) reported the detailed dis¬
tribution of the amine in various areas of the brain.
These findings were subsequently confirmed by other group
of workers, Twarog and Page (1953)# ^aasonen and Vogt
(195b), Bogdanski, Weieebach and Udenfriend (1956)*
The presence in brain of pHT and amines of the
catecholamine series (Vogt 1954 and Carlsson 1959) has
led to speculation as to the roie or these suostances in
normal brain function. The finding that many psycho¬
therapeutic agents alter the metabolism of the amines
(PletscherI9t>3) has stimulated the interest of both
pharmacologists and psychiatrists, who felt it was
possible that disturbance of the metabolism of biogenic
amines may be of etiological significance in psychiatric
(Wool leyand Shaw 1954, Gaddum ana Iiameed 1954, Shaw and
Woolleyl956, Costa 1954) and neurological disorders
(Bernheimer, Blrkmeyer, Hornykiewicz 1943# Poirier and
Sourkes 1945).
In consequence an enormous amount of experimental
work has been done on the metabolism of these substances
and/
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and of the influence of drugs on their metabolism. In
this laboratory the work has continued using two
particular techniques to examine the synthesis and
breakdownof pBT. Firstly experimental techniques have
been developed to estimate in brain the known metabolites
of tryptophan along the 5-hydroxyindole pathway (Fig. l),
5~hyoroxytryptophan (5HTP), 5HT and 5-hydroxyindole->-
ylaoetic acid (5HIAA), Estimation of these metabolites
as well as tryptophan in single brain samples give a more
dynamic picture of the formation and breaxdown of the
amine. Secondly it has been shown previously (Hess and
Doepfner 19&1) that administration of L-tryptophan to
rats caused an elevation in the concentration of 5HT in
the whole brain. A "loading dose" of the precursor
L-tryptophan was given to rats in the hope of increasing
the turnover of the amine in brain. Under these
conditions metabolites not normally detectaole by the
available techniques might reach concentrations
sufficiently high to allow their estimation.
Hess, Redfield and Uaenfriend (1959) and Hess and
Doepfner (1961) also demonstrated a rise in the amine
tryptamine in brain after administration of L-tryptophan.
In that tryptamine might also have a physiological role
an attempt was made to estimate the amine along with the



























Some of the known metabolites of tryptophan along the
tryptamine and 5-hydroxyindole pathway.
k
The thesis i'aiis then into three sections:
The first section deals with the estimation of
tryptamine in tissues in normal animals and in animals
treated with L-tryptophan, with and without the amine
oxidase inhibitor, "iproniazid". The results from the
use of the method of Hess et al. (1959) are compared with
those of paper chromatography and the discrepancies
discussed. A modification of the technique of Hess et
al. (1959) ia described.
The second section describes a paper chromatographic
technique for the estimation of 5-hydroxyindoles in brain
tissue and its application to tryptophan loading in rats.
The influence of drugs on the concentration of 5-
hydroxylndole metaoolites following loading with
tryptophan is studied.
The third and final section describes experiments
in which dogs are given oral tryptophan ana the various
areas of brain examined for their content of 3-hydroxy-
indoles at varying time intervals after the administration





In 1922 Sullivan extracted a base which behaved like
tryptamine from the urine of patients suffering from
pellagra* In 195b Rodnight using ion exchange
a
chromatography of urine extracteaAsuostance which on
subsequent paper chromatography and bioassay behaved like
authentic tryptamine. A sensitive method for the de¬
tection of tryptamine in urine was developed by Sjoerdsma,
Oates,Zaltsman and Udenfriend (1959)« The amine was
extracted into benzene from alxaiinised urine and
estimated after back extraction into acid by spectro-
photofluorimetry. The identity of the amine was con¬
firmed by its fluorescent characteristics, counter current
distribution, ana its behaviour in two solvent systems
on paper chromatography. There was then, by 1959 strong
evidence to suggest that tryptamine was excreted in
urine although it was not known whether it originated
from the animals own cells or was produced by intestinal
bacteria, Werle and Mermiexen (1937) had however,
presented evidence for the production of the amine in
animal tissues. In 1959 Weissbach, King, Sjoerdsma an i
Udenfriend demonstrated the conversion of isotopicaily
labelled tryptophan to tryptamine by kidney homogenates.
The tryptamine was extracted from the tissues which had
been made alkaline into benzene and then back extracted
into/
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into acid. The amine was identified by paper chroma¬
tography and also by its suosequent conversion oy purified
amine oxidase ana aldehyde dehydrogenase to inaoi-5~
yl&cetic acid. Hess and Uaenfrierid (1959) described a
solvent extraction method for the estimation of tryptaminn
in tissues. It was similar to that employed by Weissoach
et al. (1959) consisting of an extraction into benzene
from alxalinised homogenates with suosequent back ex¬
traction into acid. The amine was, however, converted
into a more highly fluox'escent compound ana estimated by
spectrophotofluorimetry. These workers were unable to
detect tryotamine in tissues from normal animals. Hess,
Hedfield and Udenfriend 0-959) found measurable qusntities
following the administration of either tryptophan or
amine oxidase inhibitors. This remained the method
employed by subsequent workers for the estimation of
tryptamine (Green and Sawyer 19oO, Hess and Qoepfner 1961,
Weber and Horita (I9b5)«
In this laboratory during a study of the effects of
tryptophan administration in rats on the concentration of
5-hydroxyindoles in orain using a paper chromatographic
method we attempted to examine in parallel the levels of
tryptamine In the extracts. Although for vax-ious reasons
the method did not prove entirely satisfactory it was
apparent that tryptamine could not be detected in the
brains of noi»mai rats, and that after administration of
tryptophan/
7
tryptophan only trace* amounts ( >0 <.0. 2 pg) of
tryptamine were present.
It seemed then that there was a discrepancy between
the results obtained by solvent extraction and those
obtained by paper chromatography. In consequence the
method of Hess and Uaenfriend (1959) was modified by the
addition of an ion exchange chromatographic separation
of tryptophan from tryptamine prior to solvent extraction,
The first section (Section A) then deals with the use of
paper chromatography in the estimation of tr-yptamine.
The stcond section deals with the modified method
of Hess and Udenfriend (1959) and its application to
brain tissue (Section B), A comparison is made between
the results obtained by the original and modified methods
and a likely cause for the discrepancy between the results
obtained by the two is demonstrated.
The discussion also, contains present views on the
possib Le biogenesis of ti'yytamine in brain.
£
Trace amounts of tryptamine indicates that the
activation spectrum of the sample after the norharman
procedure, shows two peaks at 310 and 360 mp, the
intensity of which are not sufficiently high above the





The conversion of tryptamine to norharman (Fig. 2)
was originally described by Kerraaek, Perkin and
Robinson (1921) using the Pictet-Spengler reaction (l91l)<
Hess, Redfield and Udenfriend (1959) employed the
procedure to convert tx-yp taurine to norharman and to
estimate the concentration of tx'yptamine indirectly by
X"eauing the fluorescence intensity of the norharman
derived therefrom.
The procedure was oriefly as follows. The de-
px'oteixiised tissue extract containing tryptamine was
made up to 6 ml with 0.1 N HaSO* in 15 nil glass tubes.
To this solution was added 0.2 ml 18% (w/v) formaldehyde
solution. After mixing, glass bubbles were placed on
the tubes and these wer*e heated with continuous shaking,
in a boiling water oath for 20 min. Hydrogen peroxide
(0.2 ml of 5 vol- 30 vol diluted 1 in b) was added and
the tubes allowed to remain for a further 20 min in the
water bath. Th* +,,bes were then removed, stoppered and
cooled. Vigorous shaking at this time liberated oxygen
which othei'wise tended to form bubbles in the cuvette and
interfere with fluoi'imetric estimation. The fluorescence















OVER-ALL REACTION FOR CONVERSION OF TRYPTAMINE TO NORHARMAN
Intermediate compounds in the conversion of tryptamine
to norh&rman.
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recording spectrophotofiuorimeter with the fluorescence
monochromatar set at i+30 mp (uncorrected). The activation
spectrum (Fig. 3) was recorded from 2p0 mp to i+00 mp.
Activation ! maxima were ootained at 3&Q mp and 310 mp.
This gave some degree of specificity to the procedure.
The fluorescence intensity of the :activation maximum
at 360 mp was used to give a quantitative estimate to the
amount of tryptarnine in the extract. In experiments with
tissues known amounts of tryptamine were taken through
the procedure to give estimates of recoveries. The blank
was obtained by taking the fluorescence at 360 mp of
pure solutions of reagents taken through the procedure.
Specificity of procedure
It is to be noted that the condensation reaction can
occur with other indole-ethylamines, although highly
fluorescent compounds are not produced by the 5-
hydroxyin ,ole derivatives. Tryptophan, when put through
the condensation reaction, yields a fiuorphor with
identical fluorescence characteristics with those of
norharman. This fiuorphor has also in paper chromato-
gx*aphy, identical Rf values in two solvent systems
(n-butanol: acetic acids water; 12:3:3; Rf 0.69 5%l
ammonia Rf 0.15). In consequence the reaction was also




ACTIVATION SCAN OF NORHARMAN
FLUORESCENCE AT 450my.




Limits of sensitivity of norharraan procedure
Quantities oi' tryptamine from 0,1 to 100 p.g were
treated by the norharman procedure as described above.
The relationship oetween the quantity oi" amine and the
fluorescence intensity of the norharman was found to be
linear up to 10 pg. After this there was no increase
in fluorescence with an increase in concentration of
tryptamine (i?lg. h). Consequently when aeterrnining
tryptamine or tryptophan content of tissues the final
extract was diluted so that it would not contain more
than 10 p,g of these substances.
Application of the norharman procedure in the estimation
of tryptophan in tissues.
The procedure is a modification of the method of
Hess and Udenfriend (1959) as applied by Guroff and
(Jdenfriend (1962).
(a) Brain and liver
Brain and liver homogenates were prepared as on
p.28 or on p,57 depending on the subsequent method of
estimation of tryptamine. Brain homogenate (0,5 ml)






CONC. OF TRYPTAMINE IN pg. par sample
lb
in 15 ml glass stoppered, centrifuge tubes. After mixing
by gentle inversion the proteins were precipitated by
the dropwise addition of 1,0 ml 30/* (w/v) trichloracetic
acid. The contents were mixed by gentle inversion and
allowed to stand for precisely 10 min. The precipitate
was centrifuged down at 2,j00 r.p.m, for 10 min. Three
mi of the supernatant were pipetted into 15 ml stoppered
tubes and made up to 6 ml with 0,1 N Ha30*• The
quantity of supernatant from tissues expected to contain
a high tryptophan content (i.e. from tryptophan lot red
animals) was 0.5 ml. This was also made up to fc> ml with
0,1 N liiSO*, These extracts were subjected to the
norharman proceaure as described above,
(b) Plasma and whole Dlood
The procedure was identical with that of brain except
that 0,1 ml of plasma or whole oiood was pipetted into
5,4 ml distilled deionised water prior to precipitation
with trichloracetic acid.
Recoveries
Known quantities of tryptophan were added to the
tissue homogenate, plasma or whole blood when these had
been diiuteu «ith distilled water. A pure solution of
tryptophan (lOpg/ml in water) was prepared, 2pg (0.2 ml)
being added to homogenates or plasma from controx animals
and/
15
and I0p.g (1 ml) to homogenates or plasma fi'om tryptophan
loaded animals. The recoveries of' these amounts of tryp¬
tophan which were tahen through the entire procedure
give a quantitative value to the estimates of tryptophan
in the tissues examined.
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SECTION A
Paper chromatographic separation in the estimation
of tryptamine
METHOD
In Section II (p. 57 )a method for the estimation
of 5-hydroxyindoles in brain and plasma involving
separation by paper chromatography is described. An
attempt was made to develop the method in such a way
that the tx*yp tannine content could be measured in parallel
in the same samples. The method for the estimation of
tryptamine diverges only at the stage of elution from
the paper chx*omatogram (p. 63 )• The paper chromatogram
was divided into 1 cm strips and these eluted into 6 ml
0,1 N Ha SO*. After standing for 15 min with occasional
gentle inversion the paper strip was removed, the volume
recorded and the eluate made up to 6 ml with 0.1 N Ha SO4
the eluate was divided into two, 3 ml being used for
5-hydroxyindole estimation. The other 3 ml of the eluate
was taken and made up to 6 ml in a 15 ml glass stoppered
tube. This was then put through the norharraan procedure.
Quantities (i+00 mpg to 800 mpg) of tryptamine were taken





It was found that recoveries of known quantities of
trypt&mine added to brain ana taken through the procedure
were highly variaoie (15-70%). It was also difficult
with the solvent system eraployed(n-outanol: acetic acid:
water, 12:3:5) to achieve a complete separation of
tryptamine from the large quantities of tryptophan
extracted from the tissues of animals pretreated with this
amino acid.
Tryptophan when applied as a marker in tissue
extracts was found to have a greater Hf than when pplied
in pure solution. Consequently no portion of the chroma-
togram between tryptophan and tryptamine was devoid of
norharman reacting material. A final disadvantage of
paper chromatography was itB failure to separate tryptaminsi
n-
(Rf 0.72 in butanol: acetic acid: water, 12:3:5) from
two substances which appear at i*f'e 0.6 and 0.75 in this
solvent system. They were detected after the norharman
reaction because of the formation of fluorophors with
an activation maximum at 310 mp when the fluorimeter
monochromator is set at 450 mp, the emission maximum
for norharman. Thus these fiuorophores obscured the
fluorescence characteristics of tryptamine when they are
eluted together with the amine from the paper ana often
ren&eraa timation of tryptamine impossible. These
ftuorophoi-es were present in relatively large amounts in
chromatograms of extracts of dog plasma and rat brain.
They/
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They may well he the fluorophors reported by Hess,
Redfield ana Udeafriend (1939) to be present in the
benzene extracts from dog liver. Figure 3 shows that
extracts of dog plasma container amounts of these
fluorophores which increased with time after tryptophan
loading with a different r te of rise in each fluorophor.
They may be derivatives of tryptophan on the kynurenine
metabolic pathway which are present in increased amounts
following tryptophan loaning, ( Michael, Drummond,
Anderson and Good, 19^4).
Application of Method and Results
Only three experiments for the estimation of trypta-
mine by paper chromatography can oe considered successful
from the point of view of both absolute separation of
tryptamine from tryptophan and a blank sufficiently low
as not to obscure the characteristic norh&rman spectrum.
1. Treatment of rats with tryptophan alone
Wistar strain rats 180 g. were given a dose of
tryptophan 800 mg/kg "by intraper i toner * L J- ction. The
animals were xiried by decapitation in groups of three at
varying time intervals up to 8 hr afterwards and estimates
made of brain tryptamine by the method described above.
Hesur uo
No tryptamine was detected in the brains of un¬
treated animals. 'Trace' amounts of tryptamine ( pO i <^0. 2
s
M-g/g)were detected in orainAof rats 1 hr after the in¬
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Fluorescence intensity of fluorophores appearing in
dog plasma at varying times after tryptophan loading#
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hr were oosoured by other fluorescent compounds running
to the Rf of tryptamine in the solvent system employed.
2. Treatment of rats with tryptophan following
preti'eatment with a monoamine oxidase inhibitor.
Wistar strain rats, 160 g were injected intra¬
muscularly with iproniazid phosphate in a dose of 5 mg/kg
for five days prior to an intrapei i toneal dose of
tryptophan (600 mg/kg) as described on p. 56. The animals
were Killed by decapitation in groups of three and the pooled
brain examined for tryptamine content.
Results
There was no tryptamine detectable in the brains of
animals treated with iproniazid alone. Following loading
with tryptophan, tryptamine appeared in 'trace' amounts
at 30 min ( ^Q^<0.2 pg/g) and reached a peak con¬
centration of 0.63 jrg/g at 1 hr (Table l). By 4 hr only
'trace' amounts of tryptamine could be detected, and at
6 hr none. The sensitivity of the paper chromatography
procedure was low, the limit of detection being 0.2 pg/g
or
of tissue/ per 2 ml plasma.
3. Estimation of tryptamine in human plasma following
tryptophan loaning
A human subject was given a dose of 5 g. of tryptophan
after fasting for 12 hr. dlood was taken ofi by vene¬




Concentration oi' tryptamine in rat drain as estimated
oy paper chromatography. The animals were pre-
treated with iproniazid 5 rag/&g for 5 days prior to




Iproniaz id 0 KD*
Iproniazid +
tryptophan 30 rain > 0 , < 0. 2
1 hr 0.85
2 hr 0.48
k hi' >0 <0.2
I
8 hr KD
3E KD = not detected «0, 2 pg/g)
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tryptophan and placed inheparinisedplastic tubes. The
blood was centrifuged immediately and the plasma frozen
until assay oy paper chromatography.
Results
The results (Table 2) show a rise in tryptamine in
plasma which is maximal at 1 hr. Small out detectable
quantities of the amine in plasma are still present
6 hr after the ingestion of tryptophan.
23
TABLii 2
Concentration of tryptophan in
human plasma after an oral dose


















WD = not detected. Less than 0.1 pg/ml
2h
3KCTI0K 3
A modification of the method of Hess and
Udenfrlend (1959) incorporating
Ion exchange column chromatography
IHTKQDUCT 1Oh
Although the method involving separation by paper
chromatography for the estimation of tryptamine in tissues
had disadvantages the results obtained for the con¬
centration of the amine in tissues of animals treated with
h-tryptophan (300 mg/kg) with and without iproniszid
(lpO rag/kg) were lower than those reported by Hess et al,
(1959) (Taoie 3 and d). The possibility that tryptophan
was a contaminant in the procedure of Hess and Udenfriend
(1959) was considered and the method modified by the
incorporation of an ion exchange column chromatography
step for the separation of tryptophan from tryptamine
prior to solvent extraction. The original method is








Concentration of tryptamine in guinea pig
brain and livex after pretreatment with
iproniazid phosphate lpO mg/kg for 1 hr
with or without L-tryptophan 800 mg/kg,
the animals being Killed 2 hr aftex* the
administration of the amino acid. From







<0.1 (5)* <0.1 (7)





3.7 (4) 0.8 (5)
*
The number of animals is shown in parentheses.
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TABLE 4
Comparison of monoamine oxidase inhibitors on trypta-
mine formation in guinea pig brain and liver from
Hess, Redfield and Udenfrierl (1959).
Tryptamine (pg/g)








1 0.3 0. 6





Animals were pre-treated with 3 mg/kg of JB-516 or
150 mg/kg of iproniazid, intraperitoneally. After
the pre-treatment period 600 nig/kg of L-tryptophan
was injected intraperitonealiy and the animals were
killed 2 hr later.
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collected from the neck wound into a polythene tube
containing heparin (0.2 ml; looo I.U,/ml). The contents
of the tube were mixed by gentle shaking.
Iproniazid phosphate (60 mg/ml in saline) was ad¬
ministered by intraperitoneal injection to 200 g, guinea
pigs in groups of three, in a dose of 150 mg/kg. Sixteen
hours later, L-tryptophan (600 mg/kg) was given by the
intraperitoneal route to the; axiimais in a 2 ml saline
suspension, prepared as described by Hess et al. (1959).
The animals were killed in groups of three at 20, i+0,
60, 60 and 120 min following the administration of
tryptophan. Further groups of guinea pigs were given
L—tryptophan by the same route, without pretreatment
with iproniazid, and killed at comparable times following
the administration of the amino acid. A group of un¬
treated animals and a group treated 16 hr previously with
iproniazid, but without injection of tryptophan, were
examined as controls.
Preparation of tissue and plasma extracts.
Plasma: The blood was centrifuged at 2,506 r.p,m.
for 10 roin and the plasma separated off. A 2 ml portion
of the plasma was diluted to 10 ml with deionized
distilled water. Zinc sulphate solution (2 ml, 10/b w/v)
was added with mixing, The proteins were precipitated
by/
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oy the addition of 0.2 ml 20% (w/v) NaOH, when the tube
was immediately inverted gently three times to ensure
adequate mixing. After standing for 10 min, the tube
was centriruged for 5 min at 2,500 r.p.m, ana the
supernatant fluid transferred to a 10 ml beaker. After
adjustment of the pH to 7.5 (glass eiectx'ode) with 0,2
M NaOH, the solution was then ready to pass through an
ion exchange column.
Brain and liver: The brains were dissected out as
rapidly as possible and the group of three brains weighed,
These were then homogenized in an all-glass homogenizer
in 0*1 N HG1 (2 ml/g brain tissue). The homogenate was
transferred to a 50 ml glass-stoppered measuring cylinder
and the volume recorded. The homogenate was stored at
-15° prior to use (no longer than 12 hr).
To a 5 ml portion of the horaogerxate, diluted to 9 ml
with deionized distilled water in a glass-stoppered
centrifuge tube, was added 1.0 ml 4 N perchloric acid
arid the contents of the tube mixed by repeated inversions,
After standing for 10 min, the precirjitated proteins
were seaimanted by centrii'ugation at 2,500 r.p.m. for
10 rnin. The supernatant fluid was transferred to a 10 ml
beaker and the pH adjusted to 7.5 (glass electrode) by
dropwise addition, with constant stii*ring, of 5 N and theh
0.2 N KQH. The contents of the oeaker were transferred
to a 10 ml centrifuge tube and cerrtrifuged at 2,500 r.p.mj,
for 5 min. The supernatant fluid was separated from the
precipitated/
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precipitated potassium perchlox-ate and passed through
an ion exchange column,
A weighed portion (aoout 3 g.) of liver was
removed from each animal and the pooled tissue subjected
to the same analytical procedures as brain.
The estimation of ti'yptamine in tissues by the solvent
extraction technique of Hess and Udenfriend (1939)
(Method l)
To 3 ml of tissue homogenate (as prepared above)
in a glass-stoppered centrifuge tuoe swasadded 0.3 ml
of 10 N NaOH to bring the pR to aoout 11, Twenty ml
of benzene werethen added and the tube was shaken for
13 min on an automatic shaker. The tube wascentrifuged
and as much of the oenzene as possiole was transferred
to another glass stoppered30 ml centrifuge tube con¬
taining 4 ml of 0,1 N HaSO*• This tube was shaken for
5 min on an automatic shaker, centrifuged, and 3 mi of
the acid layer transferred to a 13 ml stoppered tube.
The volume was made up to 6 ml with 3 ml 0.1 N H3SO4. and
the solution put through the norharman procedure. The
fluorescence Intensity of the norbarman formed was de¬
termined using an Amineo-Bowman spectrofiuorimeter.
Modification of method of Hess and Udenfriend
(a) Ionexchange column chromatography/
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(a) Ion exchange column chromatography
(Method 2)
The method, a modification of the procedure of
Oates (1901) is dependent on t e adsorption of tryptamine
on a column of suitable cation exchange resin under
conditions in which tryptophan is not adsorbed. The
tryptamine is eluted from the column with strong acid,
A column, 70 mm x 7 mm diameter, of Araoeriite ion
exchange resi 1 C,G. 50 type 1, 100-200 mesh, a weak
cation exchange resin, was employed. Before use, the
resin was treated as follows. It was first stirred
for 30 min with 3 vol. N HC1 and the acid was decanted
off and the resin washed by decantation with distilled
deionizea water until no chloride was detectaoie in the
supernatant fluid on addition of a few drops 2.5% (w/v)
silver nitrate solution. The resin was stirred twice with
3 vol, 3 N NEUOH for 30 min. The NH*0H was decanted off
and the resin washed repeatedly with distilled water
until the pH of the supernatant fluid was 9« The resin
was finally treated with 0.2 M ammonium acetate buffer,
pH 7«5» until the buffer pH remained unchanged after
standing in contact with the resin for at least 12 hr.
The resin was stored in this ouf^er solution. After
preparation of the resin column, 5 ml 0.02 M ammonium
acetate buffer, pH 7*5, were passed through before
applying the sample solution to be chromatographed.
(b) Column chromatography of extracts/
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(b) Column chromatography of extracts
Deproteinized extracts ol' Drain, liver, or plasma
(6-10 ml) were passed through the column at approximately
0,5 ml/min. Then 15 ml 0,02 M ammonium acetate Duffer,
pH 7.5, followed Dy k ml 0.1 N H2S0* were passed through
the column at approximately 0.5 ml/min and the effluents
discarded. Tryptamine was eluted from the column by the
passage of 6 ml N K 30* at 0.2 ml/min, all of the eluate
being collected.
Estimation of tryptamine in the column eluate by the
norharman procedure.
The column eluate was adjusted to pH 11 (universal
inaicator paper) by the dropwise addition of 10 N NaOH
and shaken with 20 ml benzene for 5 rain. The tryptamine
in the benzene extract
was returned to aqueous solution by shaking for 5 rain,
with 6.0 ml 0.1 N HaSO*• A 5. 5 ml portion of the acid
extract was >ut through the norharman procedure. The
fluorescence intensity of the norharman thus formed from
tryptamine was determined, using an Aminco-Bowman
spectrofluorimeter. The tryptamine'content of the eluate
was determined from the fluox*escenee intensity reading
at 360 mp (activation): il+dO mp (fluorescence); in
comparison with that obtained from 1.0 pg tryptamine
added to another portion of the orain homogenate and
processed in parallel with the sample. A blank for the
norharman/
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noi'harman reaction was determined from the norharman
procedure on the eLuate from pure solutions run through
the column.
Calibration of Method 2
Since the inclusion of the ion exchange chromato¬
graphy step appeared to give a sensitive and specific
method for the estimation of tryptamine, an experiment
was performed to calibrate the method. Amounts of
tryptamine, from 50-400 mpg, were added to 5 ml portions
of brain homogenates and the quantity of tryptamine
estimated by the method. The results (Fig. 6) were found
to be linear in this range and an amount as low as
30 mpg/g of Drain was measuraole.
The fluorescence from the orain sample without
tryptamine added was the same as that from pure solutions
\
of reagt its taken through the procedure.
Recoveries
The mean recoveries of 1 pg quantities of tryptamine
added to 3 ml brain homogenate and cariied through the
procedure was 47.3% (8.D. 6.9; eight estimations). The
mean recoveries of 0,5 pg quantities of tryptamine in
2 ml plasma carried through the procedure was 54.2%
(S,D. o.4; eleven estimations). These recoveries are low
because of the relatively poor- partition of tryptamine
between benzene and the aqueous phase at pH li.
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FIGURE 6
Fluorescence of norharman formed from tryptamine added
to brain homogenate from untreated guinea pigs, analysed
hy modified method of Hess et al, (1959) (Method 2),
The fluorescence from the orain sample without tryptaming
added is the same as that from pure solutions of reagentu
taken through the procedure.
3k
A comparison ox' tryptamine estimations in guinea pig
brain and liver by the solvent extraction method of
Hess and Udenfrlend (1339) _(Method l) and the modified
method as described above (Method 2).
Horaogenates of liver and brain were made from the
tissues of animals as described above. A 3.0 ml portion
of each homogenate as examined by the solvent extraction
procedure of Hess et al. (1959) and a 5.0 ml portion by
the modified technique. The results (Table 5) show a
discrepancy between the values for the concentration of
ed
tryptamine in the tissues ootain^oy the two methods.
Table 6 shows the high concentration of tryptophan found
in these tissues and plasma at the times the animals were
Killed.
Investigation of discrepancy between estimated tryptamine
concentr tlons in orain by the method of Hess and
Uuenfriend and by the modified technique
(a) Effect of high concentrations of tissue tryptophan
on the estimates of tryptamine
Brain homogenates were prepared from control guinea
pigs, L-tryptophan (250 p.g/g) was added to the homo¬
genate and this was analysed in triplicate portions by
the method of Hess and Udenfriend (1959) (Method l).
This/
TABLE5
Concentrationoftryptamineiguineagbr dliversestimatedyh solventextractionproc durefHessal.(Meth dl)bycolumnchromatography(Method2)atvaryingtimein ervalsft rtintr perito ealadm nistrationf' L-»tryptophan(800mg/kg)withandit outpretrea m ntf r16hwithiproniazid phosphate(150mg/kg).Thevaluesriv nsp /gndeachstimateifroooled tissuefromhreani als. BrainLiver
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This homogenate, with added tryptophan, was also analysed
in triplicate oy the modified procedure (Method 2), The
results showed that in Method 1 tryptophan was carried over
to the final acid phase and converted to norharman.
Tryptamine was therefore apparently present in a con¬
centration of 0,to pg/g. No tryptophan was found to he
carried through Method 2,
(b) Identification of indolic substances in final
extracts from two methods.
Thin layer chromatography of extract from method of
Hess and Udenfriend.
A benzene extract of 18 g. of pooled whole brain
from guinea pigs treated with tryptophan and iproniazid
and Killed 2 hr following the administration of the amino
acid, was prepared by the method of Hess and Udenfriend
(1939)* One ml of U0% acetic acid was added and the
benzene evaporated almost to dryness under a stream of
nitrogen at 55°C. This extract contained consideraole
amounts of lipid and was unsuitaole for direct appiicatior
to thin layer chromatogrems. Initial paper chromatography
was used to purify the extract. The residue was taken up
in 10 ml of benzene and the tryptamine extracted with
shaking into 3 ml 0.1 N H2SCU in a stoppered centrifuge
tube. The tube was centrifuged at 2,500 r.p.m, for 10
min and the acid phase pipetted off. This was aajusted
to pK U (Bromophenol blue paper) with careful addition
of/
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of solid potassium c&r-oonate and the solution evaporated
to near dryness at 55°C on a vacuum pump. The residue
was taxen up in 0.2 ml 80% (v/v) methanol containing
ascorbic acid 30 mg% (w/v) ad applied to a paper strip
5 cm wide under nitrogen, quantities of tryptophan and
tryptamine were added to an identical extract to act as
marivers and the chroma togram developed in isopropanol:
35% (w/v) ammonia: water; (17:1:3)»
After dr; ing in nitrogen the marker chromatogram
was divideu iongituainally ana half stained with
cinnamaldehyde reagent (Jepson 1963) to give the position
of tryptamine and tryptophan. Appropriate strips from
the other half of the marker and from the extract
chromatograms were eluted into h ml and then 3 ml 40%
acetic acid. These eluates were reduced to near dryness
in a vacuum pump at 55°C» taken up in 0,1 ml 80% (v/v)
methanol and ascorbic acid 50 mg/t> (w/v) and applied to a
thin layer plate of silica gel Q under nitrogen and then
developed in butanoli acetic acid: water? (12:3:5)«
Sufficient tryptamine ana tx-yptophan was eluted from
half the marker paper chromatogi'am to again act as a
marker on the thin layer plate. The ixxdolie substances
were visualised by spraying with einn&maldehyde x*eagent.
The above procedure was adopted using butanol:
acetic acid: water; (12:3:5) as a developing agent
for the preliminary paper chromatography and methyl ace tar
isopropanol: 25% (w/v) ammonia; (9:7:4) as developing
agent/
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agent for the thin layer chromatography.
Two substances were detected in the extract
chromatograms which oehaved like authentic tryptophan
and tryptamine (Tab1e 7) (Plate l),
) Thin Iayhr chromatography of extract produced by modified
technique (Method 2).
Hornogenate from 36 g. of pooled brain of guinea
pigs treated with ooth iproniazid (150 rag/Kg) and killed
at 2 hr following administration of L-tryptophan (600
mg/kg) were subjected to the analytical procedure of the
modified method, the benzene extracts of the amine eluate
being pooled. To this was added 1 ml kO% acetic acid
and the mixture evaporated to near dryness as described
above. Portions of the extract were applied to thin layer*
plates ox silica gel G using 0,1 ml 60fo (v/v) methanol,
iiuanUt .es of tryptamine were added to portions of the
extract to act as a marker. The plates were developed in
three solvent systems (Taole 6). The plates were dried
in nitrogen and visualised with cinnamaldehyde, or ultra
violet fluorescence following spraying with Prochazka
reagent (Stahl 1965), In the extract chromatograms a
single substance corresponding to authentic tryptamine
was detected. No second inuolic substance corresponding
to tryptophan was found.
Column chromatography of extracts produced oy the method
of Hess and Udenfriend/
TABLh7
Rfvaluesofthindolicsubstancesintwosolventy t msisilicag&Gfoundinthefi alextractoflbgfbr infromni alstrea edwithiproniazid150g/kgandtryptophan500mg/kgiMet od1(Hesstal*1939),foll wingpreliminarypurificationbypaperchromatography.
nfvalue





Authentic tryptamine markerin brainextract
Butanol- aceticcid- water (12:3:3)





Isopropanol- 35%ammonia- water (17:1:3)







Thin layer chromatography of "brain extract on silica
gel in methyl acetate: i3opropancl:2!$ ammonia (h5*35:20)
TABLE8
Rfvaluesorindolisubstancethres lve tyst msisilicgG found,ithebenzeneextractftaminefractiotheioex hange columnafterextractioof3g.br inguineapi^streatedw h ipi'oniazld150mg/kga atryptoph n800r g/kg. Rfvalue SolventIndoleTryptaminem rker inbrainextract Methylac tate-isopropanol- ammonia(9:7:4) Butanol-aceticcid-water (12:3:5) Chioroforrn-methanol aceticid(15:4:1)0.68 0.50 0.20
0.68 0.50 0.20
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Column chromatography of extracts produced by the method,
of Hess and Uienfriend
Homogenates of Drain were prepared from guinea pigs
treated with iproniazid 150 mg/kg with and without
tryptophan 500 mg/kg. Fifteen ml of each brain homo-
genate was extracted into benzene and oack-extracted
into 0.1 N H2004 oy Method 1. The resulting 15 ml of
acid was then divided into two portions, one of 12 ml
and the other of 3 ml. On the 3 ml portion tryptamine
was estimated by the norharman procedure. The 12 ml
portion was adjusted to pH (glass electrode) with
N NaOH and run through a column identical with that-used
in Method 2. All the effluents and eluates were
collected in 3 ml aiiquots and these put through .the
norharman procedure. Five pg of ti ptamine was added
as an internal standard to comparable quantities of the
brain homogenates and ta.een through the method, prior to
the addition of the 12 ml of buffered solution to the
column 1 p.g of tryptophan was added as an internal
standard. Five ml of homogenate were examined for its
tryptamine content by the modified method of liese et al,
(1959).
The results (Table 9) show the final acid extract as
prepared by the solvent extraction method to contain two
components which give norharmsu reaction. The first is
in the eluate
eluted from the column^in which the authentic tryptophan
is/
TABLEq
EBtimatioxioftryptamineinbrhomogenatf guineags,e t dw htryptoph n andiproniazidbythreemetho s.Thimalw rgiveni i zid,150g/kg6 beforer ceivingtryptophan,BOOmg/kg.M thod1:solventextractionethfH ss etal.(1559)*M thod2:modifiedethoincorporatingnexchangecolumnchr mat g aphy. Method3:solventx ractionmethofoll wbyc lumchromatography. Treetm ntMethod1 (l-ig/g)Tryptamine Method2 (jAg/g)Method3 (lAg/g)Tryptophanin benzeneextracts fromMethod1.* (jAg/g)














*Tryptophanestimated^oycolumnchromatographft ebenz nextractsfM hod1
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is contained, and che second in the eiuate containing
authentic tryptamine, Quantitatively, addition of the
two components could account for the apparent tryptamine
as found in the solvent extraction technique.
The tryptamine content of these brain homogenates
as estimated by Method 2 (0,20 jxg/g) agreed well with the
amount of the amine present in the amine fraction from
the solvent extraction technique of Hess and Udenfriend
as determined after separation from the tryptophan fractSojn.
by column chromatography, (0,1b pg/g) (Table 9 ),
Estimation of plasma tryptamine
The content of tryptamine in plasma was estimated
by Method 2, The results (Pig. 7, Table 1^) show the
amine to oe present in plasma in low concentrations after
the administration of ipi-oniazid and tryptophan. The
levers never greatly exceed those found in brain at the
same time. Following administration of tryptophan alone,
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TIME AFTER TRYPTOPHAN INJECTION
Concent! ation of tryptamine in guinea pig brain and. plssmja
as estimated by the modified procedure of Hess et al.
(1959) (Method 2) at varying time intervals alter the
intraperitoneal administration of L~tryptophan (800 mg/kfij)
with pre-treatment for 16 hr with iproniazid phosphate




Concentration of tryptami ,e (fxg/ml) in guinea pig plasma
following administration jf tryptophan (800 rag/kg) to




Exp, 1 Exp. 2 Exp, 3
Iproniazid 0 Trace+ ND* ND
Iproniazid +
tryptophan 20 0.04 ND Trace
40 Trace Trace 0.06
60 Q.0& Trace 0.09
80 0.15 0.04 0.06
120 0.12 0.06 0.06
120 0.14
*




The method described here is basically that re¬
ported by Hess and Udenfriend (1P59) with the essential
additional step of ion exchange chromatography. In our
hands, the original procedure gave falsely high values
for the estimates of tryptamine in the brains of animals
which had been given a tryptophan load, with or without
pretreatment with an amine oxidase inhibitor. The error
was traced to a transfer of a portion of the brain
tryptophan to the benzene phase and finally to the acid
extract, in spite of all efforts to prevent any mechanical
carry over. Since tryptophan yields a fluorophor
identical in characteristies with that obtained from
tryptarnine, the estimates of the latter were too high.
The presence of tryptophan in the tryptamine extracts
for fluorimetry was demonstrated in several ways.
Tryptophan was added to homogenates of brain from normal
animals, which contained no detectable ti'yptainine, to
give an amino acid concentration similar to that found
in the orains of animals treated with tryptophan.
Processed by the method of Hess and Udenfriend (1959)
such normal brain homogenates apparently contained 0.6
M-s/g of tryptamine. The acid extract obtained by the
method of Hess and Udenfriend (1959) from the brains of
animals treated with tryptophan after prior administration
of/
U9
of an amine oxidase inhibitor was passed through an ion
exchange column and norharman producing material was
found in two eluates, one of which would have been
expected to contain tryptophan and trie other tryptamine.
The norharman yielding material in the two fractions
accounted for the total apparent tryptamine in the
original acid extract (Table 9 )• Finally, it was
demonstrated by thin layer chromatography on silica gel,
using two solvent systems, that the acid extracts con¬
tained indolic substances with Rf values identical to
those of authentic tryptophan and tryptamine (Table 7 )•
These techniques of identification were reduplicated
for the final extract of the modified method of Kess and
Udenfriend (1959) (Method 2). Tryptophan added to normal
brain tissue was found not to reach the final stage of
this procedure. Thin layer chromatography in three
solvent systems (Taole 8 ) of the final extract showed
only one indolic component with Rf values identical with
those of authentic tryptamine.
The question arises as to why the identification
procedures of the original workers did not reveal the
separate components present in the final extracts. The
answer is prouaoly that tryptamine pen- se was not
identifier from tissues, but the norharman reaction was
performed on liver extracts and the resulting fluorophor
identified by its chromatographic behaviour on paper in
two solvent systems, in comparison with authentic
norharman./
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norharman. It is apparent in retrospect that any
contaminating tryptophan present would have oeerx con¬
verted to a fluorophor with identical fluorescence
characteristics to norharman and also behaving the same
way in the solvent systems used as authentic norharman.
Hess and Udenfriend state that in pure solution no
interference by tryptophan occurs even when the amino
acid is in 500-fold excess of the amine. This we also
found to be true of pure solution. It did not hold,
however, for brain homogenates, and may be due to ad-
J
sorption of the amino acid to some component of brain
tissue (e.g. liplus) with subsequent carry over into the
benzene phase. A similar phenomenon was observed for the
and Hamberg
catechol amines by Von BulerA(l949)« Consideration of
the tryptophan levels in the orain of animals pretreated
with the amino acid (Taoie 6 ) show concentrations
considerably exceeding 500 times the threshold con¬
centration for the estimation of tryptamine by the
me thod (0.1 Hg/g).
There are inconsistencies in the literature re¬
garding the changes in the level of brain tryptamine
following the administration of L-tryptophan, with and
without amine oxidase inhibitors which are explicable on
the basis of methodological error. Hess et al. (1959)
failed to detect the amine in the brain of normal rats,
guinea pigs, or dogs. However, 2 hr after aurainistratior.
of tryptophan to guinea pigs, in a dose of 500 mg/kg,
they/
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they found tryptamine to be present in brain in a
concentration of 1.4 pg/g. Pretreatment with iproniazid
150 mg/kg, prior to administration or tryptophan, resulted
paradoxically in a fall in the concentration of the amine
to 0,6 jig/g. In a later paper, Hess and Doepfner (1961)
in dmilar expex'iments using the same method of estimation
but a smaller dose of tryptophan (200 mg/kg), found 0.11+
pg/g of tryptamine in the Drains of rats 2 hr after ad¬
ministration of the amino acid. Pretreatment of these
animals with iproniazid (150 mg/kg) prior to the dose
of tryptophan ied to an increase in the brain tryptamine
to 0.37 jrg/g at 2 hr.
Weber and Borita (1963) during the in vivo in¬
vestigation of the conversion of tryptophan to $ET in
rat brain, estimated the concentration of tryptamine by
the method of Hess and Udenfriend (1959)* They treated
rats with doses or tryptophan (200 mg/kg) with and without,
preti eatment with the amine oxidase Inhibitor 2-pbenyl-
cyclopropyl amine 5 mg/kg subcutaneously lb hr prior to
administration of the amino acid. The animals were norma]),
partially (stomach intestines and spleen), or totally
(stomach intestines, spleen, kidneys and liver) eviscerate|i
The levels of tryptamine reached in Drain were 0.6 pg/g
when tryptophan was administered whether or not there was
pretreatment with amine oxidase inhibitor. Evisceration
had no effect on these levels. These authors comment
that in view of the fact that tryptamine is a better
substrate/ '
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substrate for amine oxidase than 5HT (Erspalmer et al.
I960) it is strange that the levels of tryptamine iii
brain are apparently uninfluenced by amine oxidase
inhibitor.
In our investigations, using the modified procedure
(Method 2) for the estimation of tryptamine, the amine
was found in brain only after treatment with both amine
oxidase inhibitor and L-tryptophan (Table 5 *'ig.7 )•
The amine was detected at 60 min in low concentrations
and rose slowly over the 2 hr period of the experiment.
Liver, on the other hand, had detectable levels of
tryptamine after treatment of the animals with amine
oxidase inhibitor alone. Combining the drug with ad¬
ministration of tryptophan produced very high con¬
centrations (Taole 5 ). Plasma tryptamine levels became
detectable at 20 min after tryptophan and iproniazld,
the levels still rising at 2 hr. These results did not
demonstrate a high plasma to brain gradient in the
concentration of tryptamine.
Biogenesis of tryptamine
Tryptamine does, then, appear in orain under certain




Tryptamine may be formed in brain by the decarboxy¬
lation of tryptophan. The enzyme, L-aromatie amino acid
decarboxylase, capable of effecting this conversion, is
present in brain (Lovenberg, Weissbach and Udenfriend
1962). The tryptamine may then be converted by monoamine
oxidase and aldehyde dehydrogenase to indol-3-ylacetic
acid. Failure to detect tryptamine in concentrations
which can be estimated by the technique described may be
due to its rapid destruction by amine oxidase, in the
absence of any storage mechanism. Only when this enzyme
is inhibited by iproniazid, and under conditions of
increased turnover along the tryptamine pathway, is there
a rise in the amine to detectable levels.
Tryptamine detected in brain may oe synthetised at
other sites, transported in the plasma, and penetrate
into brain across the blood brain barrier, Tedeschi and
Tedeschi (1959) injected tryptamine intravenously into
rats ana noted the onset of convulsions and tremors. They
found that these effects were potentiated in duration and
severity by amine oxidase inhibitors, and postulated that
tryptamine penetrated brain and stimulated 5HT receptors.
Green and Sawyer (i960) repeated this procedure and at
the same time estimated tryptamine in brain. They were
able to show increases in the Drain concentration of
tryptamine, following the intravenous administration
of the 5 mg/kg of the amine (0,173+0.019 jig/g) (Mean+
S,E,M. ), However, each rat received at least 1,000 pg
of/
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of tryptamine by intravenous injection. The animals were
killed 75 seconds after this dose and it would seem
probable that at this time the plasma orain concentration
gradient for tryptamine was extremely high. Under these
conditions it is not surprising the amine penetrated the
blood Drain barrier. The concentration of tryptamine
in blood was not, however, estimated during the course
of these experiments. Penetration into brain, excluding
active transport, would depend on lipid solubility and
ionisation afbody pH, and on these considerations trypt-
araine should penetrate the blood orain barrier.
In our investigations tryptamine was present in
plasma at the time of detection in orain, rising, as in
brain until the animals were killed. The question as to
whether the tryptamine present in the Drain of these
animals is formed in brain or taken from peripheral sites
is still unresolved.
lndol-3-ylacetie acid in brain might be used as an
index of tryptamine turnover. In preliminary investi¬
gations the acid has been detected in brain after ad¬
ministration of tryptophan. It was, however, present in
samples of plasma taken at the same time, and hence that
present in brain may have crossed the blood brain carrier
from plasma. At this stage then we cannot tell whether
the orain has the potential to synthesise tryptamine from
tryptophan.
SECTION 2
Tryptophan loading in rets
55.
INTRODUCTION
In an attempt to examine all the metabolites of
tryptophan along the p-hy&roxyindole pathway a paper
chromatographic method was developed to estimate 5HTP, 5HT
and 5HIAA from the same brain homogenate. During the
preliminary experiments on the method it was found that
the major source of loss of pure solution of the 5-
hydroxyindoles added to brain homogenate was during
evaporation of the aqueous phase obtained after acetone
precipitation ana subsequently blowing off the ecetone
with nitrogen. The optimal pH at which the solution was
evaporated was found to be below 5. The acid used in the
initial protein precipitation was also important.
Evaporation from N/10 HC1 resulted in some loss of the
5-hydroxyindole. This was minimised by the addition of
ascorbic acid. The use of acetic acid in the brain
homogenates gave better recoveries of 5HT taken through
the procedure than any other acid which we employed in
homogenisation. Initially a temperature of 37°C was used
on a water pressure vacuum pump. Under these conditions
it toox auout 45 min to evaporate 4 ml of aqueous solution,.
5-Hydroxyindoles tended to be destroyed under these con¬
ditions. Using a temperature of 55°C and an efficient mech¬
anical vacuum pump this volume of ayueous was evaporated
to near dryness in 5 rain, with almost 100% recovery.
The full details of the final method are given to¬




Auimals. Male Wistar rats 150-180 g (mean weight
170 g) were usecl. For 10 days prior to the experiment
the animals were maintained on 'Blue Cross' diet k'l B
(Rank). They were housed in groups oi' three and remained)
in these groups during the experiment, the tissues and
blood from each group being pooled for the various
estimations^ the animals were transferred to the
laboratory on the evening before the experiment. Food,
but not water, was removed from the cages 2k hr before
the experiment.
Tryptophan loading. A suspension of L-tryptophan
(li+0 mg/ml) was prepared for administration by grinding
first with a few drops of Twetn 80 and then diluting
with further trituration in 0.9% NaCl. This was given
intraperitoneally in amounts equivalent to tryptophan
800 rag/kg body weight (Mess et al. 1959). Injected rats
were killed by decapitation at various time intervals up
to 8 hr after 'loading'.
Blood was collected from the neck wounds Into a
polythene tube containing heparin (0.2 ml of 1,000 I.U./niL)
and stored at -15°C until estimations were carried out.
In one expex-iment, 5 ml blood was centrifuged for 5 min
at 2,500 rev/min to obtain plasma.
Preparation of brain extracts./
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Preparation of orain extracts. Solvents of
Analytical Reagent grade and aeionized distilled water
were used throughout. The brains were dissected out as
rapidly as possible, the cerebellum removed and the
group of three brains weighed. They were homogenised in
an all-glass homogenizer in 40% (v/v) acetic acid, 1,0
nil/g brain tissue. To the homogenate, a further 2.0
ml/g 20% acetic acid was added ana the homogenization
repeated. The homogenate was transferred to a 25 ml
glass-stoppered measuring cylinder ana, after the
addition of a few drops of 2-octanol to break the froth,
the volume was recorded and the homogenate was allowed
to stand at 4° for at least 30 min. After thorough
mixing, a 4.0 ml portion of the homogenate Wc.s pipetted
into a 35 ml glass-stoppered centrifuge tuoe, and to this
was added 24 ml acetone at 4° to precipitate protein.
After mixing, the extract was kept at -15° for 45 min and
then the precipitate was removed by centrifugation. A
24 ml portion of the supernatant fluid was stored over¬
night in a glass-stoppered tuoe at 4°.
The following day, the acetone was evaporated off
by means of a jet of nitrogen and the bulk of the lipid
removed from the remaining aqueous phase by extraction
with 16 ml, followed oy d ml, light petroleum (b.p. 40-
60°C). After addition of ascorbic acid, (0.1 mi of 50 mg
per 100 ml freshly prepared) the aqueous phase was
evaporated/
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evaporated to damp uryness under reduced pi'tssure
(external temp. 53° )• During this evaporation, sufficient
acetic acid remains in the aqueous extract to maintain
the pH at 3-4# a pH at which the 5-hydroxyindoles are
most stable. The evaporation, under these conditions,
should take less than 10 miru
In each experiment, two additional portions of one
of the homogenates wex*e carried through the aoove ex¬
traction procedure. To the first was added 0,8 pg each
of 5HT, 5HTP and 5HIAA oef'ore protein precipitation to
serve as internal standards throughout the procedure.
To the second specimen, the three 5-hydroxyindoles were
added to the final residue from the extraction process
in amounts sufficient to give visioie colourations on
the developed chromatogram
Paper Chromatography
The final residue was tr&nsferred in 0.2 ml followed
by 0,1 ml bO'fa (w/v) methanol containing ascorbic acid
(50 mg per 100 ml) to a 5 cm wide paper chromatogram
(Whatman No. 1 paper) by replicate applications using a
capillary tube to give a 1 cm oand. During application
the solvent w&s removed in a continuous stream of nitrogen.
The ascending chromatogram was developed in butan-l-ols
acetic acid: water (12:3:5 by vol.) in a nitrogen
atmosphere at room temperature overnight (15-16 hr solvent
run of 24-25 cm).
The/
The developed, chromatogram was oi'ied in a glass
tank, through which was passed & stream of nitrogen. The
positions of' the 50H indoles were estaolished from the
marker ehromatograras. Appropriate sections of the
sample chromatogram were elated with 4.2 ml 0.1 N H2SO4.
by .immersion and gentle agitation in glass-stoppered tubes,
After 15 mxn the paper strips were removed, the volume
of each eluate recorded and, if necessary, made up to
4.0 ml with 0.1 N HaSO*. Cone. HC1 (2.0 ml containing
ascorbic acid 50 mg per 100 ml) was added and the samples
read against a standard of 5HT in a Parrand recording
spectrophotofluorlmettr (Ashcroft, Crawford, Binns and
MacDougall, 1964). The relative fluorescences of standard
solutions of 5HT, 5HTP and 5HIAA were determined.
Localisation and identification of the pOH-indole
compounds in a chromatogram of orain extract. This was
achieved (a) by locatioxx with reference to a parallel
chromatogram of authentic 5HT, 5HTP and 5HIAA and (b) by
precise location of the 50H-indoles on the orain extract
chromatogram oy fluorimetric analyses of sequential
segments of the chromatogram.
It was found that the Rf values of 5HT, pnlAA or
5HTP applied in brain extracts and applied in pure solutio|a
were not identical, the greatest disparity oceuring with
/Table 11)
the amine./^Routinely, therefore, the positions of these
substances in chromatograms of brain extracts were













3HT 0.43 0. 50
5KIAA 0.70 0. to8
Ascending paper chromatography in butan-l-ol: acetic
acid: water (12:3*5 by vol.)
TABLE 12






96 + 10.9 (8)
—
|
55 + 6.9 (9)
0. b jig of each of the 5-hyciroxyindoles was
added to the homogenates.
X.
Mean _+ standard deviation (no. of experiments]
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brain extract, to which had been added 5HT, 5HIAA and
5BTP in amounts sufficient to permit easy visualisation
of the indoles (a) by the charaeteristic pinxish
fluorescence in ultra violet light, while the chromatogras
still retained a small amount of acetic acid from the
m-
chromatographic solvent (Mitoma, Weissbach and Udenfriend,
1955) and (b) by the colour reaction with Ehrlich's
reagent (Rodnight, 1956), and (c) by cinnamaldehyde
( Jepson 1963)
While 5KTP and 5HT were separated by several cm,
only about 2 cm separated the upper boundary of the 5HT
area from the lower ooundary of the 5HIAA area. It was,
therefore, essential that the division between these two
areas should oe accurately located. Templates were made
up from paper strips on which were marked the proposed
(Fig. 8)
sections of the chromatogram. / To allow for slight
differences in the extent of sorvent flow in the extract
and 'marker' chromatograns, six such templates were pre¬
pared, varying in length by 0.5 cm, the shortest being
1.5 cm less than, and the longest 1.5 cm greater than
the distance from the origin to the solvent front on
the 'marker* chromatogram. The positions of the proposed
cuts were marked on each template at the appropriate
points calculated from the Rf values on the 'marker'




Left: Diagram of 'strip* chromatogram of 5-hydroxyindole
compounds developea in butan->i-ol:acetic acid:water
(.12:3:5 by vol). Indoles located by the colour
reaction with Lhrlich's reagent.
fiight: Template defining positions of strips for sample
chromatogram.
63.
dried chromatogram of a orain extract was aligned with
the template appropriate to the solvent front position.
The appropriate sections were cut and dropped into the
eluting fluid as quickly as possible; nine consecutive
regions were analysed. The presence of 50R indoles in
those sections of the chromatograms postulated to contain
none would point either to poor separation, or to the
presence of an unexpected 50R indole, but there were no
detectable amounts of 5HT, 5HIAA or 5HTP in the eluates
of those sections.
Measurement of tryptophan in orain extracts and
whole blood as described on p. 12
Measurement of 3fTP in plasma. To 2.0 ml plasma
were added 0.4 ml acetic acid, and the mixture left at
4° for 30 min before aduing lb ml acetone at 4°. The
further preparation of the extract and the subsequent
chromatography was then carried out as for the brain
extracts. The strip of the chromatogram corresponding
to the 5KTP marker was eluted and the 5HTP assayed
spectrofiuorimetrically.
Confirmation of the identity of substances in the
'51-iT1 and ' 5HIAA' sections of chromatograms of orain
extracts. In a few experiments, two additional methods
of identification were used; (a) confirmation of the
basic or acidic nature of the 5-hydroxyindole compounds,
using solvent extinction procedures on the eluted compounds
and/
6d.
and (o) comparison of biological and fluorescence assays.
(a) Solvent extraction. In one experiment, the
eluates from the chromatogram strips corresponding to the
marker 5HT and 5HIAA positions were subjected to the
solvent extraction procedures, whilst in a second ex¬
periment only the 5HI.AA strips were treated in this way.
The concentration of 5-hyaroxyindoles in the eluates
was first assayed fluoriraetrically in 3 N HC1, The
eluates in 3 N HCI were then saturated with NaCl and
extracted with diethyl ether, using a modification of
the method or Udenfriend, Titus and Weissbach (1935) de¬
scribed by Ashcroft and Sharman (1962) for the estimation
of 5HIAA, and the acid 5-Hydroxyindole compounds measured
spectrofluorimetrically.
The aqueous phase, after the ether extraction, was
adjusted with 20% NaOH (w/v, Analar) to pH 10, using
phenoiphthaLein as internal indicator and basic 5-
hydroxyindoie compounds were extracted and measured,
using the method of Bogdanski, Pletscher, Brodie and
Udenfriend (1956).
The concentration of basic and acidic 5-hydroxyindoIe
compounds in the original eluates were calculated by
reference to internal standards carried through the
extraction procedure.
(b) Comparison of biological andiluorescence assay.
This was kindly performed by Dr. T,3,B. Crawford.
Extracts were prepared from the brains of animals killed
2 hr after loading with tryptophan BOO mg/kg and also
of/
65.
of control animals. The appropriate strips for '5HIAA*
and '5HT1 from the developed chromatogram were placed
in glass tubes and dried in vacuo in a desiccator con¬
taining NaOH pellets, in order to remove any traces of
acetic acid. The strips were eluted with 0.9$ (w/v)
KaCl and the eluates subjected to fluorescence assays,
carried out as descrioed above; ana to biological assays





TaDle 12 shows the results of the recovery ex¬
periments of 0.0 of 5HT, 5H1Ah and 5HT added to brain
homogenate and taxen through the procedure. Recoveries
of 3HTP were lower than those for pHT or 5HIAA, the loss
occurring during protein precipitation. The reported
estimates of the concentration of pHTP, 5HT and 5HIAA in
brain samples have been corrected for the mean recovery of
each inuole ootained during this series of experiments.
Recovery of pHTP from plasma in a single experiment was
67%*
Iuentity of supstances in 'phi? 'and ^HIAA1 sections of
chromatogram
(a) A comparison of direct estimation of 5-hydroxyindoles
in the eluates from 1 5HT1 and '5HIAA* strips and estimates
of basic and acinic p-hydroxyindole compounas in the
strips, obtained by the solvent extraction techniques,
are shown in Table 13. There was good quantitative
agreement octween pre- and post-extraction estimates and
was
no basic 5-hydroxyindole found in the '5HIAA* strip, or
acidic 3-hydroxyindoie in the 15HT* strip.
(b) A compax-ison of the fiuorimetry and biological assay
of eluates from '5HT' and '5HIAA' strips is given in Table
k/
TABLE13
































































































lif. No biological activity was detected in the '5HIAA1
strip. In the 15HT' strip, biological assay gave higher
results (0,07-0,08 p,g higher) than fluorescence assay,
both in unloaded and tryptophan loaded animals. These
results indicate the presence of a second substance with
a biological activity (as measured on the rat uterus)
equivalent to O.O7-O.O8 jig 5HT per ml eluate, the
concentration being unaltered by tryptophan loading,




1. Variation In dose or tryptophan
Tryptophan was administered, intraperitoneally as a
suspension ±k0 mg/ml in 0.9% saline in doses oi' i+00 rag/kg
800mg/kg
^and 1600 mg/kg body weight and for each dose level a
group of animals was killed 1, 2 and hr after injection.
Drug treatments
(a) a-Methyl dopa was administered as a suspension,
li+0 mg/ml in 0.9% saline, in a dose of 800 mg/kg, followed
1 hr later by tryptophan 800 mg/kg, both substances being
given intraperitoneally. The animals were killed at 0.5,
1, 2, k» 6 and 8 hr after the tryptophan was given. As a
control, a further group of animals, to which no tryptophajn
was given, was Killed 1 hr after administration of
a,-methyl dopa.
(b) Iproniazid phosphate 25 mg/ral in 0.9% saline
was given by intramuscular injection in a dose of 25 mg/kg
daily for 5 days, the time of the last dose being 1 hr
before injecting 800 mg/kg tryptophan intraperitoneally.
The animals were killed at the same times after tryptophan
administration as in (a). Animals treated for 5 days
with iproniazid, but not tryptophan, were used as conti'ols.
Confirmation of the identity of substance in pKIr section




In the course of the experiments, the x-esuits of the
application of the analytical procedure to extracts of
orain from animals treated with a-methyl dopa before
ti*yptophan administration indicated the presence of 5HTP,
Supplementary evidence of the identity of 5HTP was obtained,
as follows. The appropriate section of the paper' chroma-
togram of brain extract was eluted in 2 ml 20% (v/v) acetic
acid. The eluate was evaporated to damp dryness under
reduced pressure (external temperature 55°). The residue,
dissolved in 0,2 ml 80% methanol (v/v) containing 5° rag
per 100 ml ascorbic acid, was applied to a 5 cm wide
Whatman No, 1 paper strip and chromatogr'aphed in parallel
with 5HTP in the solvent system composed of aqueous
NaCl8%: acetic acia (100:1 by vol) in an atmosphere of
nitrogen. Eluates from sequential 1 cm strips of the
developed chromatogram, dried in a stream of nitrogen,
were made in 0,1 N HaS04 (4.0 ml). After addition of
2.0 ml conc. HC1 containing 50 mg pei' 100 ml ascorbic acid,
each eluate was examined specti'ophotofluorimetrically.
In this way, the sample chromatogram was shown to contain
material with the fluox'escence characteristics of a 5-hy-
droxyindole (max, activation 300 mp, max, fluorescence
550 mp uncorrected) located solely at the same position on
the chromatogram as authentic 5HTP, The small amount of




Uptake of amino acids by brain tissue.
The uptake of 5HTP into orain has not Qeen studied,
hut Table 15 illustrates the relationship between whole
blood and brain concentrations of tryptophan. This
relationship would not oe expected to be a simple one,
as factors such as binding of tryptophan to plasma protein
and uptake by red cells (McMenamy, Lund and Oncley, 1957)
make calculation of the concentration of freely diffusiole
plasma tryptophan impossible from the figures given for
whole blood. However, it is postulated that any signifi¬
cant changes in the tissue uptake of tryptophan would be
reflected in changing blood/brain ratios.
The ulood/Drain ratio is seen. to increase rapidly
during the first half-hour after loading, as a result of
the failure of brain uptake processes to keep pace with
the increase in blood tryptophan levels. Between 1 and
2 hr, the ratio decreases as brain levels continue to rise
whilst blood levels fall. At 2 and i+ hr, the ratio is
lower than In the unloaded animal, as the fall in brain
levels is slower than that in blood. By 8 hr, the ratio
is again returning to normal.
Following treatment with a-methyl dopa, the olood and
brain concentrations of tryptophan (Taoiel6 ) must be
compared with those following administration of tryptophan
alone./
TABLE15
Tryptophanconcentr tioniratioociandr itvarioustimefterint per toneal administrationofL-tryptophan.
Timeaft r tryptophan (hr)
Blood tryptophan (jig/ml) \
Mean blood trypto- phan (tig/ml)
Brain tryptophan (M-g/g)
Mean Brain trypto¬ phan (p-g/f)
Blood/brain tryptophan ratio






























































































* Mean+Standarddevi tion.Doseftryp ophan800mg/kg.
-vj Km
T-ABLjb., 1■k»—
Tryptophanconcentrationibl odanrainfsretreatedwi-m thyldvari ustimft r L-tryptophanloading* Timeaft r tryptophan (hr)Blood trypophan (pg/ml)Mean blood trypto¬ phan (pg/ml)Brain tryptophan (ng/g)Mean brain trypto¬ phan (ng/g)
Blood/brain trypo>han ratio

































































Therateceived800mg/kga-m thyidopa1rb foreadministrationftryptophan,800g/ .
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alone. This comparison can be made oy expressing the
results as a blood/orain ratio for tryptophan (Taole 17 ).
The ratio is increased in the a-methyl dopa group, compared,
with the untreated groups, during the first 2 hr after
tryptophan administration. The difference cannot, however,
be tested for statistical significance.
In a single experiment, it was found that pretreatment
with iproniazid did not appear to alter the tryptophan
concentrations in brain or in blood at the various times
subsequent to tryptophan administration compared with
controls.
The presence of 5HTP in rat plasma follow!ng tryptophan
administration
Evidence was obtained which indicated the £>resence
of measurable amounts of 5HTP in the plasma of animals
following triptophan loaning (Table 16). None was de¬
tectable in the plasma of control animals.
Plasma levels of 5HTP were found to be lower in
animals pretreated with a-methyl dopa (Table 18).
Concentrations of 3-hydroxyindoles In rat orain following
triptophan administration.
Following administration of tryptophan to rats in a
dose of 600 mg/kg, the orain concentration of 5HT showed




Comparison of biood/orain tryptophan ratios at various
times after administration of L-tryptophan in rate with





Tryptophan alone a-methyl dopa+tryptophan
0 CO.CVI
'
(3) 2. 75 (4)
(No tryptophan)
0.3 6. 63 (3) 7.99 (3)
1 CM£>. (3) CMCM•-d (3)
2
j
1.91 (3) 2.99 (3)
a-methyl dope 800 mg/kg given 1 hr before tryptophan
800 mg/




Comparison of 5HTP concentrations in rat plasma at
various times after intraperitoneal injection of











Wo a-me? thy1 dope
pretreatment









Tryptophan 600 mg/kg, was given. Pretreatment consisted
of a-methyl dopa, 600 mg/Kg, 1 hr before tryptophan
administration. Each result represents one estimation
on pooled plasma from three rats.
TABLE
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FIGUfiE 9
Concentration of 5HIAA and 5HT in rat brain




concentration of 0.3 p.g/g to a maximum of 0.6 p.g/g within
1 hr. This concexitration was maintained during the
following 3 hr, after which it returned to the control
value within a maximum of 6 hr after the tryptophan
administration. The 5HIAA, with a control level of
0.2k pg/g also increased in concentration, but unlike
the 5HT, the concentration of the acid did not remain at
a constant maximum level during the 1 - 3 hr interval
after loading, but continued to increase, reaching 1.09
P-g/g 4 after loading. Although the same concentration
was found also at 6 hr after the tryptophan administration
we have not examined whether* the 5HIAA was maintained
at this leveloverthe 4 - fa hr interval, or whether the
concentration did, in fact, reach a higher but relatively
unsustained maximum during this period. No 5HTP was
detectaole in the orain samples at any time before or
after the tryptophan administration.
Bffect of varying the aose of tryptophan
The 5HT concentration in orain rose from a control
level of 0.32 p.g/g to a maximum of 0.7 P-g/g (Table 20).
Alteration of the amount of tryptophan administered within
the range examined did not influence the maximum level
but only its duration.
The 5HIAA concentration in orain also increased from
a control level of 0.2h p.g/g to a maximum of 1.1 p.g/g»
the rate of rise apparently being similar to that of 5HT
over/
TABLE20































































Exceptwh restated,resultsarfrominglexperim nt.chsulr sents anestimationonthepooledbrai sfr ts. * Meanconcentration+stand rddevia io(no.fexperiments)fr mTable19
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over the first hour. Similarly the 5HIAA appeared to
rise to a maximum concentration not correlated to the
tryptophan dose, Out this was reached later than with
3UT and the absolute rise was greater than that for the
amine. Again, only the duration of the maintenance of
the maximum concentration was dependent on the dose of
tryptophan administered.
The effect of varying the dose of tryptophan on the
concentrations of tryptophan in rat blood and brain is
shown in Table 21.
affect of pretreatment with a-methyl dopa followed by
tryptophan loading.
Table 19 and Fig* 9 shows the increase in the
concentration of 5HT and 5HIAA in brain, occurring after
I
.
treatment with tryptophan alone. This incxease was not
I
obsei'ved in animals treated with a-methyl dopa before
the tryptophan administration ( Taole 22and Fig.10 ),
Another 5—hydroxyindole metaoolite, considered to be
5HTP on the basis of its behaviour on paper chromatography
appeared in measurable quantities in die brain extracts.
affect of pretreatment with iproniazld on the concentrations
of 5-hyaroxylndole metaoolites in oraln following
tryptophaxx admixilstration.




Tryptophan concentrations in rat blood and oi'ain at
various time intervals after intraperitoneal injection













































Except where stated, each result represents an estimation
on the pooled blood or brain of three rats.
Mean concentration + standard deviation (no. of experi¬
ments)
TABLE22
5-Hydroxyindoleconcentrati nsibratissufa-methylopap etr tedtsvarioust e afterL-tryptophanloading.
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0.25.24 0.17 0.252.24 0.2218.20 0.12.22.17 0.21.2 •
..._..LUJ-U 0.24+0.015(4)*
0.21. 5o.23 0.12. 0.2719. 3 0.1520 0.19221 0.19.19
<0.05(4)*
0.05. 0.23. 0.114.26 0.6445.5 0.50.27.39 0.09



















2 3 4 5 6 7
HOURS AFTER TRYPTOPHAN
concentration of 5 hydroxyindoles in rat brain alfter
a«Methyl dopa 800 mg/kg, followed 1 hr later oy tryptophajn
800 mg/kg.
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! to a level higher than that reached following ad¬
ministration of tryptophan alone (Table 23and Fig. ll).
The concentration of pHT in the Drains of animals
receiving only the iproniazid also showed an increase over
that of untreated animals.
In contrast, pretreatment with iproniazid reduced
the rise in concentration of pHIAA in brain occurring
after tryptophan loading (compare Fig. 9 and ll).
At no time in these experiments was 5HTP detected
in the brain extracts.














































5HTP NOT DETECTABLE >
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HOURS AFTER TRYPTOPHAN
concentration of 5 hydroxyindoles in rat brain after




The major metabolic pathway of 5-hydroxylndoles in
brain is tryptophan 5-hycLroxytryptophan ~>5-hydroxy-
tryptamine —>? 5-hydroxyindolacetaldehyde ~s> 5-hycLroxyindoly
a.
acetic acid. The ar^lytical technique permitted the
estimation of 5HTP, 5HT and pHLAA in tissue or plasma.
An alternative metabolic pathway is the formation of the
neutrc1 metabolite 5-hydroxytryptophol from the aldehyde
in the reversible enzymic step mediated by alcohol
dehydrogenase. This has been shown to take place in rat
liver by Peldstein and Wong (1985) and in rabbit plate¬
lets by Bartholin!, Pletscher and Bruderer (1984). Ithss
alcoholformation
not been demonstrated in rat brain but^has been shownA
to be a minor metabolic pathway for the metabolism of the
catechol amines by Goldstein and Gerber (1983). The
glueuroaide of 5-hydroxytryptophol has been demonstrated
irx rat urine by Kveder, Iskric and Keglevic (1962).
In the paper chromatography procedure described,
5-hydroxytryptophol would not separate from 5HIAA in the
solvent system used (butanol: acetic acid: water; 12:3:5)
However, during the identification procedure the 5-
hyoroxyindole on the 5HIAA strip behaved as an acid and
quantitatively was recovered from an extraction procedure
which would have excluded 5-hydroxytryptophol. This does
notindicate, however, that in other circumstances the





Limiting step in the synthesis of 5HT
The blood/brain barrier prevents uptake of 5HT from
blood into brain tissue; hence the first step in the
rise in concentrations of 5HT and 5HIAA in brain following
tryptophan loading must be either the hydroxylation of
tryptophan in the brain tissue, or the uptake into brain
of 5HTP produced elsewhere in the body. Jooper and
Melcer (I96l) deduced that 5HTP must be transported in
the plasma from an extracerebral site, but, since the
amino acid had not been detected in the blood, they
suggested that it might oe carried in bound form. In
our experiments, the presence of 5HTP in plasma was
detected, but only after tryptophan loading. Recent
work oy Qal, Pocsik and Marshall (1963) and by Qrahame-
Smith (1964) has demonstrated the ability of brain tissue
to 5-hydroxylate tryptoohan.
(1964)
Sal, Morgan, Chatterjee and Marshall/investigated
the hydroxylation of tryptophan in vivo in the pigeon
and rat. They investigated the half life of intra-
cerebrally administered 5HT and found it to be in good
agreement with the half life of 5HT formed after intra-
cereorally injected tryptophan, (Table24 )• They con-
eluded from their results that although the turnover rate
of cerebral 5HT was high the potential synthesis was low.
They/
TABLB^
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They postulated that 5HT was derived from two sources
of 5HTP# The majority was derived fx-om the hydroxy la tion
of tryptophan in pei'ipheral tissues and transported to
brain and the rest from tryptophan hydroxylated in brain#
The results of Weber and Horita (1965) in the rat dis¬
agreed with this finding. These woi-kers set out to
determine the extent of extra and intra cereoral synthesis
of 5HT. They used partielly (removal of stomach, in¬
testines and spleen) and totally (removal of liver,
kidneys, stomach, intestines and spleen) eviscerated rats.
These animals were given an intraperitoneal injection of
L-tryptophan (200 mg/kg) and the rise in brain 5ET com¬
pared with controls. Metabolism of 5HT to 5HIAA was
inhibited by the use of the amine oxidase inhibitor
(2-phenylcyciopropyi amine, POP: 5 mg/kg). They found
that in the eviscerated animal the rise in brain 5HT
after intraperitoneal tryptophan was unimpaired. They alsio
demonstrated that after slow intracarotid infusion of
tryptophan in normal rats the brain 5HT concentration
rose significantly. Assay of the 5HT content of peripheral
tissues did not show a significant rise compared with
unperfused controls. It would then seem unlikely that
5HTP was synthesised from the perfused tryptophan in
peripheral tissues and transported to brain.
In our own experiments with tryptophan alone it is
not possible to determine the origin of the cerebral 5HT,
Although 5HTP does appear in plasma after tryptophan
loading,/
loading, it does not, however, appear in drain. The
failure of 5HTP to accumulate in brain tissues, the
concentration of pHT and 5HIAA having reached steady-
levels, would indicate that hydroxylation of tryptophan
is the rate limiting step in the production of 5HT, but
a 'feed-back1 mechanian from accumulated 5HT or 5HIAA
limiting the rate of hydroxylation in an extracerebral
site, or in the brain itself is not ruled out.
Limiting concentrations of pHT and 5HI-.A and possible
existence of metabolic pools.
The coneentration of 5HT reached a maximum of
approximately 0. b pg/g brain 1 hr after loading with
.
tryptophan (600 rng/kg) following which the concentration
remained at this level for the next 3 hr. The 5HIAA
levels showed no such tendency to level out at this time,
but continued to rise, reaching an apparent maximum 4 hi1
after loading. Varying the dose of tryptophan by giving
either 400 or 1,600 rug/kg did not alter the maximum
concentrations which pHT and pHIAA reached and maintained
jin brain. At the higher doses, however, these concentra-
tion maxima were maintained for longer periods.
There are at least two possible explanations.
Firstly, the presence of a 'pool* or store, of JjjHT with a
limited capacity estimated at 0.6 pg/g brain. This having
filled, all the amine suosequentiy produced would overflow
on/
9k.
on to sites of destruction, with a continued rise of
5HIAA, An alternative explanation for the sustained
maximum concentrations of 5HT might be the existence
of a limiting supply of owing to either a maximum
'
limiting rate of formation as a result of saturation of
the hydroxylating enzyme, or to a 'feed-back* mechanism
operating on this enzyme. Given this constant supply of
5HTP, with rapid decarboxylation to 5HT, then the con¬
centration of 5KT will rapidly rise to a plateau, the lev^l
of which will depend upon the establishment of an
equiliorium between synthesis, storage and breakdown to
| 5HIAA, The 5HIAA will then continue to rise, reaching
a plateau at a later time. The level reach by 5HIAA will
I depend on the relative rates of formation from 5HT and
removal, which, in this case, will involve passage from
brain tissue into blood and CSF.
The present results showing the same maxima for 5KT
and for 5HIAA when different tryptophan loads were
I
administered give evidence against a limited storefbr
; 5hT as the sole factor for, if this were the case, the
concentration of 5HIAA would be expected to rise to
higher levels when a larger dose of tryptophan, was ad¬
ministered. The results indicate that the hydroxylation
of tryptophan is the rate-limiting step in tde bio¬
synthesis of 5HT and that at all doses of tryptophan ad¬
ministered the maximum rate of formation is reached, either
as a result of saturation of the hydroxylase by excess of
substrate/
substrate or as a
from accumulation
95.
result of a 'feed-back'
of metaoolites.
mechanism
Effect of a-methyl dopa
Several points of action on the 5-hydroxyindole
metabolic pathway in brain have been suggested for
.
a-methyl dopa. The situation has been reviewed by
Sherman and Smith (J962), who suggested the following
posaioiiities:-
1. Inhibition of the decarboxylation of 5HTP;
2. Inhibition of the uptake of amino acid precursors
into brain;
3. Displacement or release of 5HT by a-methyl dopa,
or :^ts metabolites;
4. Inhibition of amine oxidase by a-methyl dopamine,
a metabolite of a-methyl dopa,
A fifth possible mechanism, inhibition of tryptophan
hydroxylase, has oeen suggested by Pletscher, Burkard and
CJey (1964).
Inhibition by a-methyl dopa of the decarboxylation
-
|of dopa by dopa decarboxylase was demonstrated in vitro
by Sourkes (1954). It has suose-iuently been shown to
inhibit the synthesis of 5HT by inhibition of 5HTP
decarboxylase (Westermann, Balzer and Knell, 1958).
Sharman and Smith (I9b2) measured total, acidic and basic
5-hyuroxylndoles in rat orain following administration
of/
96.
of a-methyl dopa and demonstrated the appearance of
neutral and/or amphoteric 5-hyuroxyiniolic material,
probably 5HTP, whose concentration was arrived at by
subtracting the sum of basic and acidic 5-hydLroxyindoles
from the total 5-hydroxyindole concentration. The present
technique, however, enables direct estimation of 5HTP
at concentrations as low as 0.025 M-g/ml in plasma, or
0.05 pg/g in brain.
In animals treated with tryptophan alone 5HTP appeared
in the plasma but 1 did not reach detectable concentrations
in brain tissue. However, following tryptophan loading
in the animals pretreated with a-methyl dopa, 5HTP
appeared in brain in concentrations increasing with time
(Table 22, Pig. 10), while 5HT and 5HIAA failed to in¬
crease in concentration. These results are consistent
with the view that a-methyl dopa inhibits the decarboxy¬
lation of 5HTP in vivo, resulting in the accumulation of
the substrate (5HTP) before the block and in the fall in
concentration of the metabolites (5HT and 5HIAA) oeyond
it.
Despite the increase In brain concentrations of
5HTP, the plasma levels rose no higher in the a-methyi
dopa pretreated animals than in those given tryptophan
alone. The brain concentrations (pg/g) in the e(-methyl
dopa groups from 1 hr onwards reached higher ievels than
the plasma concentrations (pg/ml). This unexpected
result has two possible explanations. Firstly, amino
acid uptake into brain appears to be an active process
(Lajtha, 196k)/
(Lajha, 1964) and it may be possible, if plasma levels
are maintained and if the amino acid is not f irther
metabolised (in this case decarboxylation of 5HTP is at
least partially olocxed), for uptake to proceed against
a concentration gradient and for 5HTP to accumulate in
the brain cells. This explanation assumes that 5HTP is
formed by hydroxyiation of the tryptophan at extra¬
cerebral sites, as su'ggested by Cooper ana Meleer (1961)^ second possibility is that
and is transported to the orain in the plasma.^ pHTP
is formed in the brain by hydroxyiation of tryptophan,
in the a-methyl dopa pre-treated animals, hydroxyiation
would proceed in the brain with accumulation of 5HTP
locally, due to inhioition of the decarboxylation
mechanism. With the facts availaole, it is impossible to
decide between the two alternatives.
The active process of amino acid uptaxe into brain
tissues shows such characteristics as stereospecificity
and competition for uptake oetween amino acids within the
same subgroup (Chirlgos, Greengard and Udenfriend I960),
Gur-off and Udenfriend (1962) demonstrated in , ivo the
inhibition of uptake of tyrosine into rat brain produced
by pre-treatment with tryptophan, using the blood/brain
ratio for tyrosine as an index of uptake. In the present
experiment, during the first 2 hr after administration of
tryptophan, the blood/brain ratios for tryptophan were
higher in animals pre-treated with a-methyl dopa than in
those treated with tryptophan alone (Table 17), These
results suggest that a-methyl dopa inhibits the uptake of
tryptophan/
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tryptophan into brain. Kb direct evidence for an efi'ect
of a-methyi dopa on 5HTP uptake into brain can be ad¬
vanced, although the active uptake of this amino acid by
rat brain slices ha3 been established (Schanberg and
Giarman I960) and the inhibition of its uptake by a-methy]
dopa in rat brain slices has been demonstrated by Smith
(1963).
There was no evidence that a-methyl dopa, or its met--
abolites (Carlsson and Lindqvist, 1962), was exerting a
reserpine-like or an amine oxidase inhibitory action,
mechanisms 3 ana 1+ suggested by Sharman and Smith (1962),
The failure of 5HIAA to show a rise in concentration
speaks against a reserpine-like action (Ashcroft and
Sharman 1962) and the lack of an increase in the 5HT leveL^
is contrary to expectation if amine oxidase inhibition
was occurring. Although such mechanisms are not com¬
pletely excluded, in view of the reduced synthesis of
the pHT brought about by a-methyl dopa, it is unlikely
that they contribute to any marked extent. It is of
interest that a reserpine-like effect has been suggested
to account for the sustained decrease of eerdtral
noradrenaline arter a-methyl dopa administration (Hess,
Connamacher, Osaki and Udenfriend, 1961).
An inhibitory action on tryptophan 5-hydroxylase
has been postulated recently by Pletscher, Burkard and
Gey (1961+) to account, in part, for the effect of a-raethyh
dopa on cerebral p-hydroxyindole metabolism. Two
observations/
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observations in our experiments are consistent with,
faroof-
but not conclusive/of, such an action. Firstly, the
accumulation of 5HTP in the Drain after pre-treatinent with
a-raethyl dopa and tryptophan loading did not euual or
| surpass the combined increase in 5HT or 5HIAA observed
following tryptophan alone. This is not the result that
might be expected if decarboxylase in ibition was the
sole xflode of action of a-methyl dopa. Secondly, the
plasma concentrations of 5HTP have been found in pre¬
liminary experiments to be lower in tryptophan loaded
animals pre-treated with a-methyl dopa than in similar
animals given tryptophan alone (Table 18).
Effect of iproniazid
Iproniazid has long been known to inhibit the
enzyme monoamine oxidase (Seller and Barsky, 1952) and
to produce an increase in the concentration of endogenous
5HT in rat brain (Udenfriend, Weissbach and Bogdanski,
1957). In our experiments, animals loaded with tryptophan
when pre-treated with this inhibitor showed a rise in
concentration of 5HT in brain to 1.27 b-g/g» considerably
higher than that seen in animals treated with tryptophan
alone (0.6 pg/g). The 5HIAA did not rise to 1.1 p.g/g as
occurred in the animals treated with tryptophan alone,
but reached a much lower plateau concentration, which
was then sustained for 3 hr. It would appear that even
with/
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with this high dose of iproniazid, cerebral monoamine
oxidase inhibition is not complete. Ho effects of
iproniazid on the decarboxylation of 5hTP was demonstrated
Hie actions of the drugs used in this work on the
levels of brain amines have already been investigated
extensively (see Pletscher, 1963). The studies reported
here demonstrate how the tryptophan load technique can
!
be used to obtain a dynamic profile of the 5-hycLroxyindol<
metabolic pathway in brain. It makes possible an ex¬
amination of each point of action of a drug, studying
simultaneously uptake of amino-aeid precursors, synthesis
and breakdown of the amine.
SECTIOK 3
Tryptophan loading in dog3
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1HTR0DUCTIOK
In a communication to the British Pharmacological
Society in 1952, Amin, Crawford and Gaddura reported the
presence of 5-hydroxytryptamine (5HT) in dog orain. In
their- paper (1954) they described the detailed dis¬
tribution of this amine in discrete areas of brain. It
was apparent that the concentration of 5HT in the various
areas was not unifox-m, central structures having com¬
paratively high levels compared with cortex and
cerebellum. Of these central regions, hypothalamus and
midbrain had the highest concentrations. Values similar
to those reported oy Amin et al. who used a bioassay
technique for the estimations, were obtained ay other
workers Twarog and Page (1953)» Paasonen and Vogt (1956),
Paasoneri, McLean and Giarman (195?)» also using a bio¬
assay technique of measurement. Bogdanski, Weissbach
and Udenfriend (1957) using the fluorometric method of
assay of Bogdanski, Pletseher, Brodie and Udexxfriend
(l95t>) found the relative distribution of the amine in
brain similar to that reported by these workers. However,
the aosolute values were higher (Table25).
In the preceedxg section, it has been shown that
administration of tryptophan to rats led to an increase
in the concentration of 5HT and 5~hydroxyindol-3-y lacetic





Results obtained by various groups of workers for the concentration of 5-hydroxytryptaulne (ng/g) in dog brain.
Ares Twang andPape 1953
Amin, Crawford
and Qaddun 1954













Caudate 0 *4-<-14 (51 97 45-130 (3) 2o2 08-480 (7) 229 213-320 (4) 720 20O (9) 210 30 (4)
tlindbrain 220 40 (5)
Midbrain 190 145-230 (J> 1000 200 (3) 560 100 (5)
Thalamus 18 14-22 (2) 570 70 (6) 240 110 (5)
Hypothalamus 280 220-330 (4) 814 415-1010(3) 329 83-526 (7) 375 375 (1) 1700 300 (7) 550 160 (5)
Hippocampus 45 40-50 (2) 260 203-335 (3) 640 40 (3) 290 90 (5)
Cerebellum 140 bO-220 (2) 0 *4-ao (4) 0 712-730 (3) 9 7-12 (3) ^90 (3) 0 -50 (4)
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■ rJumoer of animals in parenthesis
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tryptophan to dogs and ooserve the change in the
tryptophan and p-hyuroxyindoies in the various areas of
brain at varying time intervals after the dose of the
amino acid. Cereorospinal fluid (CSP) was withdrawn
'
immediately prior to killing the animals and examined to
determine itB tryptophan and 5HIAA content. The present





1, p-hydroxyindoles in orain. These were
estimated by the acetone extraction of homogenates of
orain in acetic acid followed by paper chromatogrpahy,
as described on p. 57.
5HIAA in GSF was estimated by Dr. D,P.
O'Mah'oney as follows:- 4 ml of CSF was acidified with
0.1 ml of cone# HC1, and saturated with sodium chloride .
The 5HIAA was then extracted into peroxide free ether.
The ether was washed with 0.02 N sait-^saturated KG1 and
the 5HXAA back extracted into pH 6.5 0,3 M phosphate
buffer. This was acidified with 0.5 vol. conc. HC1
and estimated by spectrophotofluorimetry.
3* 5-hydroxyindoles in plasma were estimated as
described on p. 63.
4. Tryptophan in blood and oi'ain. These
estimations wex'e carried out as described on p. 12.
Tryptophan in C3F. 0.5 mi GSF was diluted to
2.5 ml with diatilleu water in a 10 ml graduated
centrifuge tuoe. Proteins were precipitated by the
addition of 0.5 ml 30% (w/v) trichloracetic acid and the
tubes allowed to stand for 10 min. They were then
centrifuged at 3000 r.p.m. for 10 rain. Two ml of the
supernatant fluid were diluted to 5 ml with 0.1 N
sulphuric acid. The tryptophan concentration in this
solution was estimated by the norharman procedure (p.8 ).
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APPLICATION OF METHODS AMD KfcSULTS
Intraperitoneal aomlnistration of tryptophan in the
anaesthetised, dog.
A ciog was anaesthetised with intravenous pento¬
barbitone. Anaesthesia was maintained throughout the
procedure. Tryptophan 200 rag/Kg was given intra-
peritoneally in suspension in saline. Venous blood was
taken ofi' at timed intervals up to 5 hr after the ad-
from the cisterna
ministration of tryptophan. CSF was withdrawn at 0, 1,
2 and 3 hr. Tryptophan was estimated in both sets of
samples, (Table 26).
The blood levels do not show an appreciable rise
when compared with those following intraperitoneal
tryptophan loading in the rat (i+00 mg/kg p. 8l) (Table2oV
or those after oral loading in the conscious dog.
(Taole 27 ).
The tryptophan in CSF showed a maximal rise of
six-fold over the control level, (Table 26).
Oral administration by capsule in the conscious animal
A venous olood sample was removed at timed intervals
after the a-uninistration of tryptophan. The blood




The concentration of tryptophan in whole
blood and CSP in dog following the intra¬









1 hi- 37.9 3.0
2 hr 23.6 3.8





Concentration of tryptophan (|xg/ml) in
whole olood following the oral admini¬












the peak concentration at 1 hr, the earliesttime of
sampling after the amino acid administration.
Oral administration of tryptophan in anaesthetised
animals subsequently allowed to recover.
Four uogs were used repeatedly in the same
experimental procedure over a period of several months.
For each experiment an animal was anaesthetised with
thiopentone sodium and whilst unconscious tryptophan
(200 rng/kg) in a suspension in water was given oy stomach
tube. The animal was allowed to recover from this
anaesthetic and then anaesthetised once more just before
sampling of the C3F was carried out. (Table 28).
The effect of prolonged anaesthesia on the tryptophan
concentration in blood, orain and GSF following oral
administration of tryptophan to the anaesthetised animal.
Animals. Adult mongrel dogs of both sexes were
used, their weights varied from 7.7 to 21.8 kg. They
were housed separately prior to the experiment and fed
on a meat diet. Food was withdrawn 18 hr prior to the
experiment, water being available throughout the
experiment. Five dogs untreated with tryptophan acted
as controls.




Concentration ox tryptophan in blood and CSF of
dogs followingan oral load of tryptophan 200 nig/kg,
recovery oeing allowed after the initial anaesthetic.
Time after ai , CSF
(jxg/ral)
0 10.0 + 2.6 (15)* 0.84 + 0.48 (10)*












Mean + Standard Deviation (number of observatione)
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induced with intravenous thippentone in the dogs prior
to the administration or tryptophan (200 rng/kg) by
stomach tube, in the form of an aqueous suspension
containing 100 mg tryptophan/ml and staoilised oy the
addition of a few drops of 1Tween 60'. Anaesthesia was
maintained throughout the remainder of the experiment.
Concentration of tryptophan in blood. Two ml of
bloou was taken from a foreleg vein prior to tryptophan
administration and at the time of sacrifice (Dogs 2A,
23, 2C and 4A). Blood was taken off prior to tryptophan
administration ana. at times §, 1, 2 and 3 hr (Dogs 3A
and 33) and also a further sample at k hr in Dog 1+B.
Tab1e2g shows the blood levels of tryptophan in five
dogs at intervals roliowing the administration of the
amino acid. The figures demonstrate in the dogs where
the whole absorption curve for tryptophan was known
that the extent and time of rise of tryptophan in olood
showed considerable variation from animal to animal.
For Dog 3A there was evidence of a rise in blood
tryptophan only 2 hr following its administration. In
Dog 3B the rise in oiood tryptophan, although occurring
in the first hour, was never particularly increased above
resting levels.
Concentration of tryptophan in brain.




Concentration of tryptophan (pg/ml) in whole blood of




2A* 2B 2C 3A 3B dA d£
0 id. 8 8. 6 10.2 8.3 8.0 10 6.d
0. 5 hr - • - 7.7 8.8 - 8.0
1 H - - - 8.2 ld.O - 11.7
2 " 30.0 2t>. 3 22.0 29.8 13.3 - 3d.O
3 " - . - - 23.5 18.8 - do.o
d * — — — — — 110 53.0
3fc
Nomenclature adopted: number indicates time of
sacrifice (hr after tryptophan load). The number
together with a letter identifies the dog killed at
that time.
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was introduced into the femoral artery and after
administration intravenously of 1 ml (5000 units)
heparin the animal was bled out. As soon as the heart
stopped oeating, the sxull was opened by means of a
viorating electric saw and the orain rapidly removed.
The brain was dissected rapidly into the various regions
to be analysed. Each part of brain was placed in a
plastic vessel, weighed and stored at -18°C for not more
than 30 min prior to homogenisation in acetic acid, in
the way descrioed for rat orain (p. 57 ).
The following areas of orain, as defined, were
analysed^
1. Cerebellum.
Hindbrain. The orain posterior to the junctic*i
between the pons and midorain extending posteriorly
as far as the lower oorder of the medulla.
3* Hypothalamus included the mamillary body but
not the hypophysis.
4. Midorain. That region from the upper border
of the pons to a point posterior to the mamillary
bodies.
5. Caudate nuclei. Vine boundaries of these areas
6. Thalamus. )were visible to the naked eye.
7. Hippocampus including the amygdala.
Occipital cortex. This was a portion of the
occipital pole of the cortex, care being taken to
include as little white matter as possible.
Tryptophan levels in orain/
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Tryptophan levels in brain. The tryptophan levels
in the orain of normal animals was found to vary between
individuals (Table30 ) anu also oetweeri regions? After
the administration of tryptophan, the brain concentration
of tryptophan rose (Table 31), The levels attained at
the time of death did not however relate to the time
interval elapsing oetween tryptophan administration and
sacrifice, nor did they consistently relate to the
concentrations in whole blood at the time of death.
This is probably due to the inconsistent rate and degree
of absorption of the amino acid from the intestine.
Tryptophan concentration in CGF. Prior to bleeding
out, the neck of the animal was flexed and p ml CSF was
tax.en from the cisterna into a polythene syringe. The
fluid was stored in an ail-glass 10 ml stoppered tube
at -ld°G until estimation of tryptophan was performed
(not more than k days).
The results (Table 32) demonstrate a rise in the
concentration of tryptophan in CSF following the
tryptophan load. The rise is, however, variaole and
not directly related to the concentration of the amino
acid in brain at the time of death,
4
For evaluation see Appendix 2 (p.i66)» (Table 5l).
TABLE30



















































































































































Concentration of tryptophan (pg/ml)






2 hr 2A 12.1
2B 4.7
2C 4.2
3 hi' 3A 3.6
3B 1.2
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The concentration of 5-hydroxyindole substances In the
.
brain, plasma and CSff ol' the anaesthetised dog.
The homogenates obtained as described, from the
above dogs (pp. 57,112) were analysed for 5-hydroxyindoles,
The concentration of 5:*hydroxyindoles in the grains
of control animals.
The estimates of the concentration of these
substahces are show in Tables 33* 5k . These figures
have not been corrected for losses inherent in the
analytical procedure.
They show the uneven distribution of the 5-
hyaroxyindolic compounds throughout the brain and also
their variation from one animal to another in any one
brain region. Midbrain and hypothalamus showed the
highest levels of both 5HIAA and 5HT. Neither 5HIAA nor
5HT was found in cerebellum and cortex. The ratio of
5HIAA to 5HT appeared to be a constant for each area.
Concentration of 5-hydroxyindoles in orain after oral
tryptophan loading.
Oral administration of tryptophan caused a rise in
both/
TABLL33
























































































































00th 5HT and 5HIAA in all areas at all times up to 4 hr
with two isolated exceptions (Tables 35 and 36)
The rise was greatest in those areas which begin with high
levels, the hypothalamus and midbrain. Trace amounts
(<0,05 |ig/g) of 3HT were fo <na in the cerebellum and
cortex of Dogs 2C and 4A. These trace amounts may have
been derived from residual platelets in the tissue, the
amount present depending on how well the animal had been
oled out* fto 5HIAA appeared in these areas following
tryptophan loading. 5HTP was not detected (< 0.Op pg/g)
in any area at any time after tryptophan loading.
The concentration of 5-hwuroxyindolea in aog plasma after
oral tryptophan loading,
Plasma obtained from Dogs 2A, 2fl and 4-A when the
animal was finally bled out was examined for p-hyaroxy-
indoles, No pKLAA or 5HTP was detected ( < 0.05 pg/ml).
Very low levels (< 0.05 jxg/ml) of 5HT were found to be
present, but as no particular precautions were taken to
avoid platelet destruction during centrifugation, it is
uncertain whether this was 'free' 5HT in plasma or that
released from platelets.
Coneentration of 5HIAA In CSF i'o11owing oral loading with
There was a steady i*ise in the concentration of
5HIAA/
TABLE35


























































































































































5HIAA in C3F following oral loading with tryptophan
mean
(Table 37). The/level of 5K1AA corresponded quite well
in its rate or rise with the p-hydroxyindoles in orain,
especially in relation to hypothalamus (Fig. 12). There
was, however, quite a wide variation between animals in
these levels at the various time intervals al ter tryptophan
loading.
Recover!es of' pHT, pHlAA and pHT? added to orain homogeneto
The three p-hydroxyinuoles in 0,2 mi aqueous solution,
containing 800 mpg of each were added to k ml of cere¬
bellum or cerebral cortex homogenate. The mixture was
processed in parallel with homogenates from these and
other orain regions. The recoveries from several such
experiments are shown in Table 38. The variability of th€
recoveries was found to be greater than that round using
rat whole orain.
Cereoellum and cerebral cortex wereused for the
recovery experiments in that the5-hydroxyindoles were not
normally found in these areas. Consequently any p-
hydU'Oxyindoies present in the recovery sample were
entirely due to added compounas and the variation in the
recovery was not influenced oy the variation due to
duplicates as would have seen the case should an area
containing p-hydroxyinaoies have been used. The figures
given for the concentrations of p-hydroxyindoles in orain




Concentration 02 5HIAA (ng/ml) in CSP following oral



































Concentration of 5 HT and 5HIAA in hypothalamus and



















Control 2 hr.s 3 hrs 4 hrs
TABLE38
Recoveries(%)f800mjxgpuresolution5-hydroxyind lesadd dt brainhomogenateandtakthroughm thod. 5-Hydi-oxy indoleOADE2BC3+AMean+S.D. 5HTP013947-85730.6+9.6h 5HT710498472631 56.5+17.7 5HIAA735044671889.8+ 3.6
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Firstly the variation in the recovery oh 500 mpig oi' the
5-hydroxyindoies was large, and correction by the use of
a mean figure for these recoveries would not have hau a
great deal of meaning. Secondly there was no evidence
that the recovery of these indoles through the method
was linear with the amount of indole added.
128
DISCUSSION
The Concentration of Tryptophan in various areas of brain
In iybO Price and West, using acetone extracts
identified tryptophan in various areas of Drain in a numhe^
of animal species. They found a wide variation in the
concentration in the different areas and, in the dog, a
large range in the concentration of this amino acid be¬
tween any one area in different animals (Taole 39 )• The
hypothalamus and pons had the highest levels; the mid¬
brain, the cerebellum and the medulla were next in order,
with spinal cord and cerebral hemispheres having the
lowest concentrations. Their estimates of the concentration
of pHT in these areas correlated fairly well with the
concentration of tryptophan in the same areas. However',
the method of estimation employed by these workers (paper
chromatography followed oy colour reaction with a spray
reagent) was insufficiently precise to give this ranking
very much significance, and was not reasonable evidence
for their hypothesis that pHT was formed from tryptophan
in urain. It is incorrect to assume that the concentration
of substrate In a particular area is an index of the
turnover of that suostrate through a particular pathway
without additional evidence.
In oar own investigations, tryptophan was estimated
in the various areas oi five control dogs (Table 30),




Concentration ol tryptophan and pHT (M-g/g) in various
areas of aog brain with approximate rank order from



































the amino awiu oetween the ax4eas. An analysis of
variance on the figures showed a significant difference
(? <0.05) in the concentration of the amino acid between
areas. When these concentrations were analysed by a
method which gave each area for each dog a rani order,
it was found that there was again a significant difference
in ranking fox' the areas (P<0.05 > 0.01), The best
estimate of rank order is shown on Table UO, Appendix 2,
Whether these absolute levels have any physiological
significance is uncertain. It is however, interesting
to note that they are very roughly inversely correlated
with the concentration of dopa decarooxylase in the
various areas as given by Bogdanski et al. (1957)
(Tabled). This enzyme is thought to oe identical with
5HT? decarboxylase (Holt z and Wester/nan 1957). This
variation in tryptophan concentration may at coia elated
with the density of a particular cell type in the areas
examined. The amino acid pool or the rate of utilisation
of tryptophan may vary from cell to ceil. It could,
however, be merely an artifact of the method of estimation
of tryptophan. This amino acid becomes strongly adsorbed
onto protein and cleavage of the adsorbed tryptophan
from the protein under the acid conditions brought about
by the aduition of trichloracetic acid. The degree of
adsorption may vary from area to area. Multiple recovery




Best estimate of rank order of brain areas with respect
to the concentration of tryptophan. Comparison of rank
order with dopa decarboxylase concentration.













Caudate nucleus 7 306
* Bogdanski et al. (1957)
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A two-way analysis of variance (Table 52 ) on these
figures shows a highly significant (P< 0.01) variation
in the concentration of tryptophan in the brains of
different uogs. This may be due to normal biological
variation or be methodological in origin.
Administration of tryptophan
Tryptophan was administered to the dogs orally
following a preliminary experiment in which a dog was
anaesthetised and an intraperitoneal injection made of
tryptophan (200 rag/kg) in saline suspension. Blood levels
of tryptophan showed no appreciaole rise (Table 2 6) in
contrast to the markedly raised levels observed following
intraperitoneal injection of tryptophan (kOO mg/kg) to
rats (p.go)» jfo view of the fact that oral dosage of 5 g*
(70 mg/kg approx.) tryptophan to man (Oswald, Ashcroft,
Berger, Bccleston, Evans and Yhaco;- o (1966) (Table i±i)
resulted consistently in high levels of tryptophan within
1 hour of administration it was decided to use oral
loading tryptophan in dogs. Initially the tryptophan
(30 mg/kg) was given in capsule form in the conscious
animal, A good rise in the concentration of the amino
acid in blood resulted (Table 27 )• A dose of 200 mg/kg
required a large number of capsules (ld-lb) and it became
difficult to administer this number even to trained logs.
Consequently the tryptophan was administered in sus¬





Concentration oi' tryptophan in whole blood following
a loading dose of 5 g. tryptophan in man.
p. -i i mmmmmmm* mm * mmm ■—
Tryptophan yg/ml
Subject H M W L
0 hours 7.3 6.9 9.2 7.5
ii
s 8.8 17.8 29.2 1+2.0
1 M 38.0 32.2 73.0 76.3
2 " 87.3 30.8 108.0 67.3
6 * 87.3 33.1+ 1+3.3 52.9
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dog with thiopentone sodium. Initially it was planned
to allow the animals to recover Trom the anaesthetic and
to readminister the anaesthetic at the time or killing
the animal, Four dogs, treated this way out not killed
at the second anaesthetic showed increases in tryptophan
in blood and CSF (Table 28 )« In another group of
animals in which it was intended to examine the brain
as well as the CSF, the first dog used was allowed to
recover from the first anaesthetic. It was not a dog
which had become used to these procedures and thereafter
showed such marked excitement that intravenous ad¬
ministration of thiopentone was impossible. It was
consequently killed under nembutal anaesthesia given
intraperitoneally. After this experience the anaesthetic
for all other animals was continued from the time of
administration of tryptophan to bleeding out and death.
Initially tryptophan in blood was estimated in this group
of animals only at the beginning of the experiment and at
the time of death. Later, when it became apparent that
the tryptophan levels were not reaching the anticipated
concentrations throughout the experiment, estimates of
tryptophan concentration in blood were carried out at
timed intervals over the full duration of the experiment.
It was found (Table 29 ) that of these dogs examined
in this way, one showed a 2 hr delay in the initial rise
in the blood concentration. (Dog 3A) while another showed
a peak blood tryptophan concentration which was consis¬
tently lower than that of other animals (Dog 3B). It
would/
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would appear theii that oral loading in the unconscious
animal does not give a predictaole rise in either blood or
brain tryptophan levels (Table 29) presumably uue to
delayed gastric emptying or impaired absorption. This may
be a major factor in causing the highly variable results
for the concentration of 5-hydroxyindoles in brain oetween
dogsxilled at the same time after the administration of
tryptophan. Subsequent experiments have shown that
intravenous administration of tryptophan (10 mg/ml in
saline) in a dose of 50 rag/&g give predictable rises in
the concentration of blood ana. brain tryptophan.
The concentration of 5-hydroxyindoles in the brains of
control animals.
The control group in this series consisted of five
dogs. There was a wide variation in the concentrations
of 5HT and 5HIAA between the areas examined (Tables 33end3i+)
The highest conce2itration of 5HT was found in midbrain and
hypothalamus. The concentration of the acid metabolite
paralleled that of the amine and was also highest in
'
midbrain and hypothalamus. The concentration of these
metabolites in specific areas, however, varied from dog"
to dog. This has been observed for 5HT by other workers
(Paasenen and Vogt, 1956; Laverty and Sharman (1965)
and may not be methodological in origin.
Changes in the concentrations of 5-hydroxyindoles in brain
ollowing oral tryptophan loading.
From/
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Prom these results (Tables 35 and 36, Fig. 13)
it can be seen that following tryptophan administration
there was a rise in the concentration of both 5HIAA and
5HT in all the areas examined, apart from cerebellum and
cortex. In these areas neither of theindoles were de¬
tectable in control animals. However, very small amounts
of 5HT (0.05 M-g/g) were detected in the cortex and
cerebellum of two animals after tryptophan loading. . These
small quantities may have been derived from blood still
present in the tissues at death in spite of the ex&-
anguination. The rise in 5HT and 5HIAA in other areas
was very variable between animals at particular times
after aaministration of tryptophan. This may be due to
a combination of biological variation and variable
tryptophan absorption. If the full absorption curve
for each dog had been known prior to death then the
animals might have fallen into a different order with
respect to the time the tryptophan had been elevated in
blood prior to killing. The present order assumes,
incorrectly, that immediately the tryptophan is administered
absorption oegins.
The significance of changes in the concentration of 5HIAA
in brain.
.Ashcroft and Sharman (ly^Z) investigated the effects
of reserpine on the concentrations of the acidic (probably
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CONCENTRATION OF 5HIAA AND 5HT IN VARIOUS AREAS OF DOG
BRAIN AT VARIOUS TIMES AFTER ORAL ADMINISTRATION OF TRYP¬
TOPHAN 200mg./kg.
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caudate nucleus of the dog. They found (Table J42 ) that
during the first two hours after the administration
of the drug (2 mg/kg intravenously) the concentration of
*
the basic 5-hydroxyindoles fell, that of acidic 5-
hydroxyindoles rose, but the concentration of the total
5-hydroxyindoies remained virtually unchanged. They
concluded that the increase in concentration of acidic
3-hydroxyindoles was prooaoly a measure of the basic
p-hydroxyindoles released from stores by the action of
the reserpine, and converted to the acid by amine oxida-se
and aldehyde dehyurogenaee. The possibility thus arose
might
that the concentration of acid p-hydroxyindoles be used
as an index of 5HT turnover.
For the concentration of 5HIAA in brain to be useful
as an index of 5HT turnover certain criteria should be
fulfilled. Firstly the catabolism of 5HT by amine oxidase
and aldehyde dehydrogenase to 5HIAA should be the major
pathway in the metabolism of the amine. Secondly the
5HIAA present in Drain must oe derived almost solely
from the amine. The amount produced via other metaoolie
pathways would require to be almost negligible in
proportion, particularly in situations in which a
decreased formation from the amine was occurring. In
connection with the foregoing suggestion of alternative
pathways for 5HIAA production it seems theoretically
possible, although there is no experimental evidence
for it that the acid might arise from 5-hyuroxyindoIyl-
pyruvic acid formed as a result of deamination of pHTP,
Thirdly/
TABLEU-2
Concentrationor50Ri dolylcompoundsthecaudatenuc eusx"d g. Concentrationsexp essedusmfig^I&lAA/gtis ufroAshcr tandSh an(1962) Total$0RAcidic5 ftBas0k indolyliindolyl compoundsco pounds Controldogs610161+485 84528631 2hrafterrese pine65O4781 2
(2mg/kgintravenously)67O557189
11+0
Thirdly for an acid metabolite to reflect changes in the
rate of synthesis of the amine it should accumulate in
brain when an increase in synthesis occurs. On the other
hand the acid should leave the Drain cell and the brain
as a whole sufficiently rapidly so that any decrease in
the turnover of the amine is quickly reflected by a
fall in the concentration of the acid roetaooiite. Pinally
the acid metabolite should not readily penetrate the orain
from plasma.
The concentration of 5KIAA present in brain tissue
at any point in time will be determined by the difference
between its rate of synthesis and rate of removal,
assuming that no further metabolism of the acid takes plac£.
A rise in the concentration of the acid inetaoolite with
time could restilt either from an increase in turnover of
the amine or from a decrease in the transport of the
metabolite out of brain. The converse of these would
hold for a fall in the concentration of the metabolite.
Its egress may be by way of the blood stream or the CSP
or both. It is not known what is the relative importance
of these processes. The changes in the levels of 5KIAA in
G8P follow quite closely changes In the levels of the acid
in brain after tryptophan loading (Pig 12 ). It seems
likely that this acid, line other organic acids might be
transported out of the CSP by some mechanism located in the
region of the fourth ventricle (Pappenheimer lgi ), pHIAA
was/
mi
was not detectable in the plasmas of dogs we have ex¬
amined aftei" tryptophan loading. There is evidence
(Milne, Crawford, Glrao and Loughridge 19^0) that this
acid is actively transported out of the plasma by the
kidney and hence the plasma is rapidly cleared of this
metabolite.
In our observations in rat and dbg brain after
tryptophan loading the rise and fall in the concentration
of 5HXAA followed closely that of 5HT, It will be seen
from Fig. 9 that, following tryptophan loading, there
was a fall in the concentration of 5HIAA in whole rat
brain of 0.6 pg/g over the two hour period covered by the
seventh and eighth hours after the tryptophan ad¬
ministration. The potential rate of loss of 5HIAA from
brain would oe higher than this in that during this period
normal or supranoriaal synthesis of 5HIAA would still be
proceeding, The level of 5HT in the stores was con¬
tinuing to decrease and was presumably being metabolised
to 5BIAA. On this evidence it would seem that 5HIAA can
leave orain fairly x-apidly.
There is, however, experimental evidence which
apparently conflicts with this conclusion. Ashcraft and
Crawford (unpublished observations) treated rats with
reserpine (p mg/kg intraperitoneally) and observed the
changes in the concentration of the 5HIAA and 5HT in whole
brain at times from 10 mixi to hr after the ad¬




Concentration of 5HT and 5HIAA in whole rat brain
up to 48 hr following the intraperitoneal injection
of reeerpine 5 mg/±cg (Ashcroft and Crawford, Un¬
published ob seivat ions).
Treatment Time 20^ ?HI + 5HXAA
■
. twi ttsZs
None 0 0. 62 0.18 0.60
Resex'pine 10 min 0.49 0. 30 0.79
45 min 0.43 0.49 0. 92
90 min 0.23 0.48 0. 71
21. 5 hr 0.07 0.46 0. 53
48 hr 0.13 0.30 0.43
was a significant fall in 5HT and rise in 5HIAA within
10 min of injection of the drug. The concentration of
the acid inetaoolite remained elevated long after the 5HT
had been depleted. In similar experiments performed on
and Werdiniue
rabbits, Roos (19 62) (Table )|)|) also found that the 5HT
concentration in brain rapidly decreased but the
concentration of 5HIAA remained elevated for some 24 hr
after the maximal depletion of 5HT. The observations
of Roos ana Ashcroft and Crawford would appear to be
against the hypothesis that the bx-ain levels of pHIAA
would be an index of pHT turnover. However, this
apparently contrary evidence is not conclusive. Other
explanations are possioie. Reserpine might increase the
turnover of 5HT in the absence of a storage mechanism for
the amiiie. Reserpine might in lex-fere with a mechanism of
active transfer transporting pHIAA from the cell in the
:brain j,n consequence a "pool" of 5HIAA would
be formed the rate ox* removal of which was determined
pux-ely by the phyaico chemical properties of 5HIAA in
relation to its permeability of lipid membralnes. Our
own observations have shown that the drug probenecid used
to influence the transport of organic aeide in kidney, is
effective in preventing the egress of 3HIAA from CSF, In
high doses Sherman (personal communication) has demon¬
strated that it causes a rise in homovtmillic acid in rat




Concentration of 5-hydroxytryptamine and 5-hydroxy-3-
ylacetie acid in raboit brain at varying intervals
following intravenous injection of reserpine (2-5 rag/&g
body weight) after Roos (1962).




6 0 hr 0.7 0.94 + 0.041
2 2 hr 0.02 1.3
2. 6 hr 0.01 1.7
5 12 hr 0. 02 1.5
2 24 hr 0. 01 1.0
2 46 hr 0.07 0.5
Ih5
3HIAA has oeea aliown to rise after administration of the
drug. This urug may well prove useful in the in¬
vestigation of this transport process.
The significance of the ratios of 3HIAA to 5HT in the
various regions of uog brain.
and 3U-
Examination of the data (TabJ.ts 33/ for 5HT and
5HIAA in the various regions of dog brain showed that
the x-atio of the concentration of the acid metabolite to
that of the amine was not constant throughout the brain
(Table ^+5 ). Although it is not possible to test by
statistical analysis whether the ratio is, in fact,
significantly different between one area and another, it
is of interest to consider the implications following the
assumption that the differences are indeed x-eal. If the
level of 5HIAA can oe equated with the turnover of 5HT
then areas with similar 5HT concentrations but different
5HIAA/3HT ratios would have different rates of turnover
of the amine and consequently the turnover of 5HT is not
related to the storage capacity for 5HT.
Qn this basis, the turnover of 5ST in the hindbrain
and thalamus would appear to be similar but greater than
that in either the caudate nucleus or the hippocampus.
Also the midbrain with 5KT levels similar to that in the





Ratio oi concentration of 5HT to 5HIAA'.' in the
various areas of 5 normal aogs.
Ares Dog Mean
1 2 3 4 5
Caudate «•» 1.7 3.2 1.0 2.8 2.2
Hindorain 1.4 0.45 1.3 0. 63 2.3 1.2
Midbrain 1.0 0.44 1.1 1.0 0.63 0.87
Thalamus 0.75 0. 68 1.2 1.5 0.68 0.96
Hypothalamus 1.8 1.1 2.8 1.0 1.4 1.6
Hippocampus 3.1 1.8 2.5 1.2 3.3 2.4
Ikl
Such conclusions are dependent on the following
additional assumptions; firstly that the facility for
removal of pKIAA does not vary from region to region;
secondly that the differences in the relative concentrations
of 5HIAA and 5HT do not merely reflect differences in the






The main advantages oi' the technique of tryptophan
loading combined with the simultaneous examination of
several metabolites in the synthesis and breakdown of
5HT is that a more dynamic picture of the metabolism
of the amine can be gained and that the action of drugs
like a-methyi aopa and iproniazid are more easily
demonstrated.
In both dog and rat there was a rise in the con¬
centrations of the 5-hydroxyindolyl compounds in brain
following oral administration of tryptophan. That these
increases took place at all was rather surprising, the
tendency being for biochemical systems to possess feed¬
back mechanisms which prevent over-synthesis of a
particular metabolite. Although these concentrations
rose, there were no apparent behavioural effects in the
conscious dog. It could well be that the release of 5HT
on to (what are still hypothetical) receptor sites was
unchanged, and the additional 5HT formed was rechannelled
into stores, or sites of loss such as monoamine oxidase.
There is indeed no reason to assume that the 5HIAA is
formed exclusively by oxidative deamination of 5HT or
indeed that at ail times after the administration of
tryptophan the proportion metabolised through any
particular pathway is constant.
From a consiaeration of experimental design the use
I of/
1^+9
of oral loading in the unconscious dog is unsatisfactory
because absorption from the gut is unpredictable and
often delayed, hence the rise in the 5-hydroxyindolts in
brain cannot be related on a time oasis from the time of
administration of the amino acid. This difficulty could
be overcome by more frequent sampling of blood with
estimation of its tryptophan content. Even so, the
absolute rise in the concentration of the amino acid
varies from animal to animal, and even in the same animal
varies between experiments. Subsequent work has shown
that reproducible changes in the concentration of 5-
hydroxyindolie compounds in brain can oe produced by the
intravenous administration of L-tryptophan in the dog.
APPENDIX
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forther Investigation of acetone ext. action procedure
as applied to dog brain.
i n mmi m ~~ m■ -^I»m - - ■*»' hw1^WIB<»,IH ■— " — " ■ • -
Sonpar ison of results of acetone extraction procedure with
L.9jti'iflilo£io acid precipitation of the acetic acid
lomogenate followed by ion exchange column chromatography.
An aliquot of brain homogenate from various areas of
the orain of dog i+3 which was being examined by paper
chromatography was analysed in parallel for its content
of 5HT by a method involving perchloric acid pre¬
cipitation and column chromatography. The actual volumes
of homogenate precipitated by this method depended on the
re idual volume after 4 ml homogenate had oeen removed from
the total for estimation by paper chromatography. don-
sequently, the volume of midbrain used was 1.5 ml, caudate
2 ml. live ml of hippocampus cerebellum, midbrain .nd
thalamus of which there is a considerable initial volume
bf homogenate, was pi'ocessed by the ion exchange method.
The method is that described for guinea pig brain in
Section 1 (p. ^q) except that to the amine containing
traction from the ion exchange column is added conc. HC1
(50/o by vol) and the concentration of 5HT estimated by
spectrophotofluorimetry on an Aminco-dowman fluorimeter.
The areas examined are shown in Table i+6.
Similar parallel estimates were made on homogenates
of/
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of brain from various areas of two dogs given an
intravenous load of tryptophan (50 mg/kg) in a 10 mg/ml
solution in saline, the animals being killed 2 and 4 hr
after injectio (dogs IV 2d and IV 40 respectively. Table
46),
The results show that analysts by the column method,
with few exceptions give consistently higher values for
the concentration of 5HT in the various areas of brain
than the estimate reached by acetone precipitation and
paper chromatography.
j&caKiination of the petrol ether phase useu to extract
lipids from the aqueous phase after acetone extraction
The two methods differ in the additional step oi the
use of petrol ether to remove lipids after acetone pre¬
cipitation. as it is possible that 5HT is lost in this
phase compiexed with lipia the petrol ether phase used
in an extraction of the extract of midbrain, thalamus and
hypothalamus was retained and analysed for its content
of 5-hydroxyindole8 (this would also contain any 5HIAA
transferreu from the extract). The petrol ether phase
was blown down to dryness with nitrogen. The lipid was
taken up in 4 ml of butanol and the 5-hydroxyindoles
extracted by shaking with 2 ml 0.1 N HaSO* after aduition
of 4 vol (16 ml) of heptane to the butanol. The 2 ml




Comparison of concentration of 5-hydroxytryptamine In
brain homogenates as estimated by acetone precipitation
and paper chromatography, perchloric acid precipitation
and column chromatography.
Dog Area PCA Acetone
and column and
paper
1+B Midbrain 2.3+ 1.307*
Caudate 0.66 0.85 rj
Thalamus 1.02 0.1+7
Hippocampus 0.57 0.37
Hind brain 0.1+5 0.55




Hind brain 0.1+1+ 0.61+
Hypothalamus 2.11+ 1.75
Cortex >0 <0.05 0.05
Cerebellum >0 <0.05 0.05




+Results corrected for 76.5% recovery of 5-HT
^Corrected for recovery of individual
experiment
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cone, HC1 added. The solution was examined oy Farrand
spectrophotofiuorimeter for the presence of compounds
with 3-hyuroxyindole fluorescence.
Only traces (>0 <0,05 M-g) of 5-hydroxyinaole could
oe detected in the petrol ether,
Extraction of precipitate remaining after acetone
precipitation with perchloric acid.
In that the difference between the two methods could
be accounted for by a difference in the percentage ex¬
traction of 5HT present in the brain (as opposed to that
quantity of pure solution added to the homogenate to act
as an internal standard) the precipitate remaining after
acetone precipitation was extracted with perchloric acid
and examined by ion exchange column chromatography. The
precipitate remaining after removal of the aqueous acetone
supernatant from midbrain and hippocampus of dog was blowr
to dryness with trogen, This was then homogenised with
10 ml 0,1+ N perchloric acid, allowed to extract overnight,
and then centrifuged. The supernatant was adjusted to
pll 7»d and run over the columns as described above. The
amine fraction was examined for the presence of 5—
was detected by this method,
■examination of supernatants by ion exchange chromatography




It was possible that the ion exchange column chroma- :
tography procedure itself for some unknown reason gave
high values for 5HT &nd hence the supernatant8 after
acetone precipitatio l and perchloric acid precipitation
were examined by ion exchange column chromatography*
The brain of a dog which had been killed by a large dose
Of intravenous Niembutal was dissected to remove midbrain
and thalamus. These parts were homogenised in 1 vol 40. s
(v/v) and 2 vol 20^ (v/v) acetic acid. Each homogenate
was divided into two portions. One portion was analysed
by perchloric acid precipitation of the homogenate followed
by ion exchange column chromatography and spectrophoto-
fiuorimetry of the amine fraction using an Aininco-Bowman
fluorimeter. The proteins of the other portion were
precipitated oy addition of 6 vol acetone and the aqueous
phase prepared as described above. The lipids were re¬
moved by shaking with petrol ether. The aqueous phase was
made up to 6 ml with distilled water and the pH adjusted
to 7.4 (glass electrode). The 5HT was estimated after
separation by column chromatography and rpectrophoto-
fluorimetry on an Amineo-Bowman spectrophotofluorimeter.
Amounts of 500 inp,g of pure solution of 5BT were added to
equal volumes of homogenate andtaxen through the procedure
to act a8 an internal standard.
After calculating for recovery the results (Table
47) show no great discrepancy between the two methods.
155.
TABLE 47
Concentration of 5HT (p-g/g) in two areas of brain
as estimated oy (a) perchloric acid precipitation
and column chromatography and (b) acetone precipi¬
tation and column chromatography.
Method








j comparison of the estimates of the concentration of
5HT by the Amlneo-Bowman and Farrana spectrophoto-
I'iuorimeter In the same samples.
The various ai'eas of the Drains of two dogs were
examined lay the procedure of acetone precipitation and
paper chromatography. The eluates from the 5HT and 5HIAA
containing strips were acidified with concentrated HCI and
for each sample the fluorescence due to the 5-hydroxyindole
present was determined using a Parrand spectrophoto-
fluoriineter and immediately therafter the determination
was repeated using; an Amineo-Bowman spectrophotof luorimetegr.
The estimates corresponding to the two determinations are
shown in Table 40 . It is evident that the estimate of
the 5-iiydroxyindole content on any one sample was higher





5HT (H-.g/&) 5HIAA (ug/g)
Parrand Aminco-Bowman Farrand Aminco Bovot
Dog 1
Midbrain 0.64 0.70 0.43 0.66
Hindbrain 0.18 0.25 0.23 0.33
Hippocampus 0. 38 0.49 0.13 0.18
Caudate 0.25 0.74 0.20 0.35
Thalamus 0. 21 0, 30 0.28 0.39
Cerebral
Cor *,ex 0.19 0.49 <0.05 0.30
??&. 2
Midbrain 0. 752 0.89 0. 70 1.06
Hypothalamus 0. 82 1.03 0. 65 0.99
Hindbrain 0. 22 0.27 0.22 0.32
Hippocampus 0. 33 0.41 0. <L J 0.35
Caurate 0.25 0. 35 0. 20 . 55
Thalamus 0.30 0.40 0. 39 0. 66
Cerebra 1




Several workers have considered whether the figures
they ootaineu for the concentration of 5HT in brain were,
for* any reason, low. Ainin, Crawford and Gaddum (1954)
used a oioassay technique to determine the concentration
of the amine. They maae comparisons between various
oioiogieal preparations and, hence, estaolished to. some
measure the specificity of their assays. This also gave
a quantitative verification of the amount of the amine
present in their final extracts. They did, however,
consider the possibility of interfering substaxxees
reducing the sensitivity of their preparations. During
their investigations, they considered that the two
possible interfering substances were adrenaline and
.
noradrenaline but the concentration of the latter as
indicated in the work of Vogt (1954) would be insufficient
.
to interfere with the estimation of 5HT. Adrenaline could,
however, have been present in certain areas in sufficient
concentration to produce inhibition of the jiological
preparation and, hence, apparently low values fox* 5HT.
Garven (i955)» investigating the problem of the
interference of adrenaline and noradrenaline in the
oioassay of 5HT extracted from dog brain, used mushroom
extracts containing polyphenol oxidase to break down any
catechol amines extracted oy the procedure of Auxin et al.
(1954). The remaixxing 5HT was assayed using the isolated
I oestrus/
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oestrus rat uterus preparation. She detected the amine
in caudate nucleus and hypothalamus obtaining higher
figures lor the concentrati on of the amine than reported
by Arnin et al. (1954) (Table 49 )• However, the bio¬
logical response of the preparation was not completely
abolished by lysergic acid diethylamide, and hence the
possibility arose that some of the biologically active
material was other than 5HT.
Another source of error is the extraction procedure
itself. Amin et al. (1954) extracted brain tissue with
20 ml of acetone per g of tissue followed by re-extractior.
of the insoluble residue with 99% acetone. Their
acceptance of the efficiency of the extraction procedure
was a 9recovery of relatively large amounts of 5HT
(5 Hg) added to 10 g of minced horse intestine. Twarog
and Page (1953) found that, using 20 vol of acetone
recoveries were 60$ from brain. Correale (1956) in¬
vestigating the concentration of acetone to water which
produced the best recoveries, found 80$ (1+ vol) to be
optimal, whereas 99% (20 vol) gave fairly low recoveries,i
Bogdanski et al. (1956) also found the recoveries using
99% acetone to be low and variable. Sharman (i960)
re-examined the extraction method of Amin, et al (1954)
and in some of his initial experiments found a variable
proportion of 5HT to remain in the precipitate following
acetone extraction. He found, however, that careful
mincing of the tissues eliminates this loss.
Another/
160.
Acetone extracts of aog hypothalamus and caudate





fiat uterus 770 150
lbl,
Another source of loss he found to oe in the
extraction of some of the 5HT into light petroieum ether
in the course of lipid re oval from the aqueous residues
left after removal of the acetone extracts. He found
quite large quantities (50/ of total) of 5HT entered this
plfase (Table 50). In our own experiments, recoveries
although somewhat variable (Table 3d), were quite high.
Even so, in the figures we obtained for 5HT in dog brain,
when corrected up for these recoveries are still low,
compared with those obtained by Sogdanski et al, (1956)
(Table 23). It would, therefore, oe necessary to postulate
either that there is consiueraole oiological variation, ant.
in the group of animals whichwe have used the levels en¬
countered oy Bogaansxi were not reached or, secondly, thai
a certain portion of the 5HT in orain did not behave
identically with the 5HT added in pure solution to
give an estimate of the recovery through the px*ocedure,
A possibility was that the tissue 5HT might be complexed
with iipid or other material ana in this form was not
completely extractable under the conditions we employ.
It might be that to oreax such cociplexes, fairly acid
conditions would oe necessary, those for instance
obtaining in the procedures of Bogdansxi et al, (1956)
The pH of their HC1 homogenates diluted with water to
9 vol is found to be about 2,0, Secondly, we may have
been losing 5HT complexed with lipid into the light




Biological estimation of 5HT axxd fluorescence
estimation of 5-hydroxyindolyl compounds in the
fractions of an acetone extract (Amin et al. ) of







extract 2.0 jig 2.8 jig
Light petroleum
washings 1.0 pg 1.7 jig
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on three samples from different Drain areas oy the method
described oy Sharman, Dut could only detect insignificant
a;aounts of 3-hydroxyindole. The difference oetween our
own extraction method ana that employed by Sharman was
that the acetone extracts were prepared in the presence
of acetic acid and this acid in the aiueous phase might
prevent the format! on of a 5HT lipid complex and, hence
reduce the extractaDility of the 5HT into the light
petroleum.
The effect on the 3HT estimates resulting from the
use of different methods of protein precipitation
was examined by comparing the estimates of the con¬
centration of 5HT in portions of the same orain homogenate
treated oy acetone precipitation and by perchloric acid
precipitation and corurnn chromatography. Higher levels
were found by the latter technique. This would tend to
support the view that we were failing to extract some
'bound' 3HT at the pH (aoout 3) of the precipitation: when
compared with that ootained during perchloric acid
precipitation (about l).
To investigate this question of extractaQility, the
concentration of 3HT obtained by precipitating a portion
of the same brain homogenate with acid acetone estimated
oy column chromatography procedure and fiuorimetry (by
Aminco-Bowman fluorimeter) was compared with the con¬
centration found by perchloric acid precipitation,
column/
Ibk
column chromatography and. fluorimetry (Aminco-Bowman
fiuorimeter). The results under the.e circumstances
v/ere in good agreement. Only two areas were, however,
examined in this way.
Precipitates incompletely extracted by the acid
acetone should contain 5HT extractable by perchloric acid.
An attempt to extract this residual 5HT by perchloric
acid followed by separation by column chromatography and
estimation (Aminco-Bowraan fluorimeter) showed negligible
amounts (< 0.1 pg) to be extracted by this procedure.
During these investigations one point had been
overlooked. The final fluorescence measurement was
carried out using either a Farrand or an Aminco-Bowman
opectrophotofluorimeter. With our- instruments, the latter
was more sensitive than the former. The Aminco-Bowman
spectrophotofluorimeter was generally used after column
chromatographic procedures when the volume of homogenate
used was smaller than for the paper chromatographic
procedure and hence greater sensitivity of the measuring
instrument was necessary. An experiment was performed
in which the eluate from paper strips containing either
5HIAA or 5hT in varying concentrations from various
areas of dog brain were measured on both instruments.
Table USshows that there was a discrepancy oetween the
estimates as obtained by measuring the fluorescence on the




It would thus appear that we have introduced an
artifact in to our methods of investiga ing the dis¬
crepancies in the reported concentration of 5hT in brain.
The estimates or the concentration of 5HT following
perchloric acid precipitation and column chromatography
were cased without exception on readings obtained from
the Aminco-Bowman spectrophotofluorimeter, those from
paper chromatography on readings obtained from the
Pari-and spectrophotofluorimeter. In the absence of any
real difference between the efficacies of the extraction
procedures, those results from procedures involving column
chromatography would give higher figures because of the
fluorimeter variation. This discrepancy does not account













1 2 3 k 5
Caudate 6,5 7 7 7 k 31.5 7
Hiudbrain 5.0 3 2 3 5 18.0 k
Midbrain 6,5 2 5 k 2 19.5 5
Thalamus 1.0 k 1 5 6 17.0 2=
Hypothalamus L.0 ■ 5 k 1 3 17.0 2=
Hippocampus 3.0 6 6 6 7 28.0 6
Cerebellum 2.0 1 3 2 1 9.0 1
28.0 28 28 28 28 1 1L0.0
Expected rank total if no difference between samples
= 205x8= 2
where m « number of columns = 5
n = number of rows = 7
If no true agreement oetween dogs the sum of squares of
differences between observed and expected rai.k totals are
maximum and given by:-
m2 (n3 -» n)
12
bmax
In that there may oe only pai'tial agreement between dogs
the sum of squares will oe S,
The/
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The coefficient of concordance, W « "§5jrx
w 339.5*^= 25(3357
= 0.485
Test of significance using Snedecora distribution of F












There is thus a significant ranking of the results
(P <0.05, >9.01).
168,
Regeneration of 'lost' hypothalamus result in dog (p. 117).
TABLE 52
Areas Dogs ^ xj
12J5 4 5
Caudate 6.1 5. 8 3.4 3.3 7.0 25.6
Hindorain 6. 6 9. 8 3. 3 t>. 5 6.4 34.6
Midbrain 6,1 10.0 4,3 6.4 7.4 34.2
Thalamus 9.5 9.7 8.0 6. 3 5.6 39.1
Hypothalamus 7.0 9.5 4.5 9.5 y' 30,5 R
Hippocampus 8.1 7.8 4.1 5.7 5.4 31.1
Cerebellum 8.4 14.3 5.0 6.6 8.2 42.7
£Xi 51. 8 66. 9 34. 6 44.5 40.0 237.8 G
Finney y' = rR ♦ cC - G(r-1) (c-lj
When y' =
r as
term to be regenerated
number of rows (Areas)
R = total of row (Hypothalamus) without missing
number
c = number of columns (Dog s)
C total of column (Dog 5) without missing
nurnoer
G = grana total without missing number •































































































Two-way analysis of variance of tryptophan concentration
In various areas of the grains of 5 dogs cont'd.
Variation (Total) =2-Exiia ~ l2J
N
= 1665.49 - (245. If
35
= 1665.49 - 1716.40
= 169.0697
Vari tion (Areas) = >_ni(x. - x)aJ J
fr] M
= 6770.31 - 1716.40
5
= 37.662
Variation (Dogs) = Eni(xi - 3iy
'
T, 2 ) - TaJL) H
i
= 12573.55 - 1710.40
= 79.6214
Error = Total - Areas - Dogs
= 169.0697 - 37.662 - 79.6214
= 51.606












SECTION 1 - Tryptamine
The method, of Hess and Udenfriend (1959) for the
estimation of tryptamine in tissues, is demonstrated to
allow the carry over of tryptophan to the final extract,
resulting in falsely high values for the amine. A
modification of the original method is described, in¬
corporating ion exchange chromatography, which gives
complete separation of these components. Using this
method, tryptamine is found neither in the brain of
normal guinea pigs, nor in animals treated with L-
tryptophan. It is found only when L-tryptophan is ad¬




SECTION 2 - Tryptophan loaning in rats
A sensitive technique for the assay of the
3-hydroxyindole compounds was devised, involving separatkri
by paper chromatography followed by elution and
jfluorimetric assay. The specificity of the analytical
procedure was determined. Concentrations of tryptophan
were measured in blood and brain tissue of the rat and
the concentrations of 5HTP, 3HT and 5HIAA were determined
in the brain at times up to 8 hr after loading with
tryptophan.
No 5HTP was detected in the brain after tryptophan
loading, although it appeared in measuraole amounts in
the plasma. The 5HT in brain rose rapidly to a level
which remained constant over a period of hours. The
5H1AA in brain also increased rapidly, reaching a maximum
at a time later than 5HT. These concentrations were
maintained for a longer period with larger doses of
tryptophan,
a-Methyl dopa treatment before tryptophan loading
prevented the increases in 5HT and 5HIAA which occur
following tryptophan administration alone, and also
resulted in the appearance of the amine precursor, 5HTP;
it may also interfere with the uptake of tryptophan from
plasma/
Ilk.
plasma into the brain. Iproniazid treatment before
tryptophan loading increased the concentration of 5HT
and diminished the rise of 5HIAA, with no apparent effect
on the uptake of tryptophan or the decarboxylation of
5HTP in the brain.
175.
SUMMARY
Section j> - Tryptophan loading in dogs.
The technique ox' estimating the concentration of
the p-hydroxyindoles and tryptophan is applied to various
areas of the brains of five normal dogs. The concentration
of the bHT and 5HIAA varies greatly from area to area,
midbrain and hypothalamus having the highest levels,
cortex and eereoellum having amounts below the limits
of detection of the method. Tryptophan also shows a
definite order in its concentration from area to area.
Following the oral administration of tryptophan
the concentration of 5UIAA and f>HT rises in ail areas and
at fil times at which estimations are made (up to hr).
Oral loaning in this case was in the unconscious animal
and, possibly because of a delay in gastric emptying,
the aosorption of tryptophan was very variable in its rate
and time of onset. As a result the rise in the 5-
hydi oxyindoles varied very greatly between dogs killed at
the same time after tryptophan loading.
176.
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